BLASTP 2.5.1+
Reference: Stephen F. Altschul, Thomas L. Madden, Alejandro
A. Schaffer, Jinghui Zhang, Zheng Zhang, Webb Miller, and
David J. Lipman (1997), "Gapped BLAST and PSI-BLAST: a new
generation of protein database search programs", Nucleic
Acids Res. 25:3389-3402.


Reference for compositional score matrix adjustment: Stephen
F. Altschul, John C. Wootton, E. Michael Gertz, Richa
Agarwala, Aleksandr Morgulis, Alejandro A. Schaffer, and
Yi-Kuo Yu (2005) "Protein database searches using
compositionally adjusted substitution matrices", FEBS J.
272:5101-5109.


RID: 48KY8GUU01R


Database: PDB protein database
           88,033 sequences; 21,903,153 total letters
Query= 
Length=239


                                                                   Score     E
Sequences producing significant alignments:                       (Bits)  Value

3VXF_H  Chain H, X/n Joint Refinement Of Human Alpha-thrombin-...  371     3e-131
1JWT_A  Chain A, Crystal Structure Of Thrombin In Complex With...  372     4e-131
1GJ5_H  Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa...  370     4e-131
1ABI_H  Chain H, Structure Of The Hirulog 3-Thrombin Complex A...  370     4e-131
1D9I_A  Chain A, Structure Of Thrombin Complexed With Selectiv...  371     5e-131
2BDY_A  Chain A, Thrombin In Complex With Inhibitor                371     5e-131
1NU9_A  Chain A, Staphylocoagulase-prethrombin-2 Complex           371     5e-131
1NM6_A  Chain A, Thrombin In Complex With Selective Macrocycli...  371     7e-131
1HAG_E  Chain E, The Isomorphous Structures Of Prethrombin2, H...  371     7e-131
3R3G_B  Chain B, Structure Of Human Thrombin With Residues 145...  370     7e-131
4H6S_B  Chain B, Crystal Structure Of Thrombin Mutant E14ea/d1...  370     9e-131
1DM4_B  Chain B, Ser195ala Mutant Of Human Thrombin Complexed ...  369     1e-130
1JOU_B  Chain B, Crystal Structure Of Native S195a Thrombin Wi...  369     1e-130
1SFQ_B  Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To...  369     1e-130
4H6T_A  Chain A, Crystal Structure Of Prethrombin-2 Mutant E14...  371     1e-130
4RKJ_B  Chain B, Crystal Structure Of Thrombin Mutant S195t (f...  369     1e-130
1BTH_H  Chain H, Structure Of Thrombin Complexed With Bovine P...  369     1e-130
3SQE_E  Chain E, Crystal Structure Of Prethrombin-2 Mutant S19...  370     1e-130
1QUR_H  Chain H, Human Alpha-Thrombin In Complex With Bivalent...  369     1e-130
3K65_B  Chain B, Crystal Structure Of Prethombin-2/fragment-2 ...  371     1e-130
2THF_B  Chain B, Structure Of Human Alpha-thrombin Y225f Mutan...  369     2e-130
1RD3_B  Chain B, 2.5a Structure Of Anticoagulant Thrombin Vari...  369     2e-130
1BBR_K  Chain K, The Structure Of Residues 7-16 Of The A Alpha...  369     2e-130
2GP9_B  Chain B, Crystal Structure Of The Slow Form Of Thrombi...  369     2e-130
1D6W_A  Chain A, Structure Of Thrombin Complexed With Selectiv...  370     2e-130
1DX5_M  Chain M, Crystal Structure Of The Thrombin-Thrombomodu...  369     2e-130
1EOJ_A  Chain A, Design Of P1' And P3' Residues Of Trivalent T...  370     3e-130
1Z8I_B  Chain B, Crystal Structure Of The Thrombin Mutant G193...  369     3e-130
2A0Q_B  Chain B, Structure Of Thrombin In 400 Mm Potassium Chl...  368     3e-130
5JDU_B  Chain B, Crystal Structure For Human Thrombin Mutant D...  368     4e-130
1MH0_A  Chain A, Crystal Structure Of The Anticoagulant Slow F...  369     5e-130
1MKW_K  Chain K, The Co-Crystal Structure Of Unliganded Bovine...  369     6e-130
1B7X_B  Chain B, Structure Of Human Alpha-Thrombin Y225i Mutan...  367     7e-130
1Z8J_B  Chain B, Crystal Structure Of The Thrombin Mutant G193...  367     7e-130
3JZ1_B  Chain B, Crystal Structure Of Human Thrombin Mutant N1...  367     8e-130
1H8I_H  Chain H, X-Ray Crystal Structure Of Human Alpha-Thromb...  367     9e-130
1ID5_H  Chain H, Crystal Structure Of Bovine Thrombin Complex ...  367     1e-129
3NXP_A  Chain A, Crystal Structure Of Human Prethrombin-1          373     1e-129
1THP_B  Chain B, Structure Of Human Alpha-Thrombin Y225p Mutan...  367     1e-129
1TWX_B  Chain B, Crystal Structure Of The Thrombin Mutant D221...  365     3e-129
2PGB_B  Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a  365     5e-129
1WBG_B  Chain B, Active Site Thrombin Inhibitors                   365     7e-129
2OD3_B  Chain B, Human Thrombin Chimera With Human Residues 18...  365     9e-129
3EE0_B  Chain B, Crystal Structure Of The W215aE217A MUTANT OF...  365     9e-129
2PUX_B  Chain B, Crystal Structure Of Murine Thrombin In Compl...  363     2e-128
2BVR_H  Chain H, Human Thrombin Complexed With Fragment-based ...  363     3e-128
1TQ0_B  Chain B, Crystal Structure Of The Potent Anticoagulant...  363     4e-128
1H8D_H  Chain H, X-Ray Structure Of The Human Alpha-Thrombin C...  363     4e-128
2OCV_B  Chain B, Structural Basis Of Na+ Activation Mimicry In...  362     6e-128
5EDM_A  Chain A, Crystal Structure Of Prothrombin Deletion Mut...  372     1e-127
5EDK_A  Chain A, Crystal Structure Of Prothrombin Deletion Mut...  372     1e-127
4NZQ_A  Chain A, Crystal Structure Of Ca2+-free Prothrombin De...  372     2e-127
1VR1_H  Chain H, Specifity For Plasminogen Activator Inhibitor-1   361     2e-127
4HZH_A  Chain A, Structure Of Recombinant Gla-domainless Proth...  371     2e-127
3GIC_B  Chain B, Structure Of Thrombin Mutant Delta(146-149e) ...  361     2e-127
1VZQ_H  Chain H, Complex Of Thrombin With Designed Inhibitor 7165  360     3e-127
3EDX_B  Chain B, Crystal Structure Of The W215aE217A MUTANT OF...  358     2e-126
1BBR_H  Chain H, The Structure Of Residues 7-16 Of The A Alpha...  200     2e-65 
1BHX_B  Chain B, X-Ray Structure Of The Complex Of Human Alpha...  195     2e-63 
2HNT_F  Chain F, Crystallographic Structure Of Human Gamma-Thr...  178     2e-57 
2PKS_C  Chain C, Thrombin In Complex With Inhibitor                176     7e-57 
1BBR_E  Chain E, The Structure Of Residues 7-16 Of The A Alpha...  176     1e-56 
1FAX_A  Chain A, Coagulation Factor Xa Inhibitor Complex           157     2e-47 
2BOK_A  Chain A, Factor Xa- Cation                                 156     5e-47 
3ENS_B  Chain B, Crystal Structure Of Human Fxa In Complex Wit...  156     6e-47 
1HCG_A  Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2...  156     6e-47 
1C5M_D  Chain D, Structural Basis For Selectivity Of A Small M...  156     8e-47 
1EZQ_A  Chain A, Crystal Structure Of Human Coagulation Factor...  156     8e-47 
2Y5F_A  Chain A, Factor Xa - Cation Inhibitor Complex              155     1e-46 
1XKA_C  Chain C, Factor Xa Complexed With A Synthetic Inhibito...  155     1e-46 
1FJS_A  Chain A, Crystal Structure Of The Inhibitor Zk-807834 ...  155     1e-46 
2GD4_H  Chain H, Crystal Structure Of The Antithrombin-S195a F...  155     2e-46 
1MQ5_A  Chain A, Crystal Structure Of 3-chloro-n-[4-chloro-2-[...  154     2e-46 
2BQ6_B  Chain B, Crystal Structure Of Factor Xa In Complex Wit...  155     2e-46 
3F6U_H  Chain H, Crystal Structure Of Human Activated Protein ...  151     4e-45 
1AUT_C  Chain C, Human Activated Protein C                         151     5e-45 
1KIG_H  Chain H, Bovine Factor Xa                                  151     5e-45 
5JBB_S  Chain S, Crystal Structure Of Factor Ixa Variant V16i ...  143     4e-42 
2WPI_S  Chain S, Factor Ixa Superactive Double Mutant              143     6e-42 
1A0J_A  Chain A, Crystal Structure Of A Non-Psychrophilic Tryp...  142     8e-42 
5JBA_S  Chain S, Crystal Structure Of Factor Ixa Variant V16i ...  142     1e-41 
4YZU_A  Chain A, Rapid Development Of Two Factor Ixa Inhibitor...  142     2e-41 
2WPH_S  Chain S, Factor Ixa Superactive Triple Mutant              141     2e-41 
5JB8_S  Chain S, Crystal Structure Of Factor Ixa Variant K98t ...  140     5e-41 
1RFN_A  Chain A, Human Coagulation Factor Ixa In Complex With ...  140     5e-41 
2WPM_S  Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited  140     5e-41 
3KCG_H  Chain H, Crystal Structure Of The Antithrombin-Factor ...  139     1e-40 
1PFX_C  Chain C, Porcine Factor Ixa                                138     4e-40 
3VEQ_B  Chain B, A Binary Complex Betwwen Bovine Pancreatic Tr...  136     2e-39 
1TAW_A  Chain A, Bovine Trypsin Complexed To Appi                  136     2e-39 
1Y59_T  Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa S...  135     3e-39 
3OTJ_E  Chain E, A Crystal Structure Of Trypsin Complexed With...  135     3e-39 
1TAB_E  Chain E, Structure Of The Trypsin-Binding Domain Of Bo...  135     3e-39 
1G3B_A  Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Sch...  135     4e-39 
2FI4_E  Chain E, Crystal Structure Of A Bpti Variant (Cys14->s...  135     4e-39 
1TGS_Z  Chain Z, Three-Dimensional Structure Of The Complex Be...  135     4e-39 
1ZZZ_A  Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Ald...  135     6e-39 
1MCT_A  Chain A, The Refined 1.6 Angstroms Resolution Crystal ...  135     6e-39 
2TLD_E  Chain E, Crystal Structure Of An Engineered Subtilisin...  134     7e-39 
1FXY_A  Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibit...  135     8e-39 

ALIGNMENTS
>3VXF_H Chain H, X/n Joint Refinement Of Human Alpha-thrombin-bivalirudin 
Complex Pd5
Length=259

 Score = 371 bits (952),  Expect = 3e-131, Method: Compositional matrix adjust.
 Identities = 162/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  258


>1JWT_A Chain A, Crystal Structure Of Thrombin In Complex With A Novel 
Bicyclic Lactam Inhibitor
Length=305

 Score = 372 bits (956),  Expect = 4e-131, Method: Compositional matrix adjust.
 Identities = 163/237 (69%), Positives = 209/237 (88%), Gaps = 1/237 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  60   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  119

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  120  IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  179

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  180  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  239

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTGGD  236
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G D
Sbjct  240  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGED  296


>1GJ5_H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa, Ser190ALA190 
PROTEASE, Structure-Based Drug Design
 1SB1_H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating 
P1 4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain Mimetics
 2PW8_H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
 3DD2_H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human Thrombin
 1GJ4_H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa, Ser190/ala190 
Protease, Structure-based Drug Design
 4UDW_H Chain H, Thrombin In Complex With 1-(2r)-2-amino-3-phenyl-propanoyl- 
N-(2,5dichlorophenyl)methylpyrrolidine-2-carboxamide
 4UE7_H Chain H, Thrombin In Complex With 1-amidinopiperidine
 4UEH_H Chain H, Thrombin In Complex With Benzamidine
 5AF9_H Chain H, Thrombin In Complex With 4-methoxy-n-(2-pyridinyl)benzamide
 5AFY_H Chain H, Thrombin In Complex With 3-chloro-benzamide
 5AFZ_H Chain H, Thrombin In Complex With (2r)-2-(benzylsulfonylamino)-n-(2-((4-carbamimidoylphenyl)methylamino)-2-oxo-propyl)-3-phenyl- 
Propanamide
 5AHG_H Chain H, Thrombin In Complex With ((4-chlorophenyl)sulfamoyl)) 
Diemethylamine
 4UFD_H Chain H, Thrombin In Complex With 4-(((1-((2s)-1-((2r)-2-(Benzylsulfonylamino)-3-phenyl-propanoyl)pyrrolidin-2-yl)-1- 
Oxo-ethyl)amino)methyl)benzamidine
 4UFE_H Chain H, Thrombin In Complex With (2r)-2-(benzylsulfonylamino)-n-(2-((4-carbamimidoylphenyl)methylamino)-2-oxo-butyl)-3-phenyl- 
Propanamide
 4UFF_H Chain H, Thrombin In Complex With (2r)-2-(benzylsulfonylamino)-n-(2-((4-carbamimidoylphenyl)methylamino)-2-oxo-ethyl)-n-methyl- 
3-phenyl-propanamide
 4UFG_H Chain H, Thrombin In Complex With (2r)-2-(benzylsulfonylamino)-n-((1s)-2-((4-carbamimidoylphenyl)methylamino)-1-methyl-2-oxo- 
Ethyl)-n-methyl-3-phenyl-propanamide Ethane
 5A2M_H Chain H, Thrombin Inhibitor
 5DO4_H Chain H, Thrombin-rna Aptamer Complex
Length=258

 Score = 370 bits (951),  Expect = 4e-131, Method: Compositional matrix adjust.
 Identities = 162/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  258


>1ABI_H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature 
Of The S' Subsites Of Substrates And Inhibitors
 1ABJ_H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature 
Of The S' Subsites Of Substrates And Inhibitors
 1DWB_H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution 
Of The Binding To Human Thrombin Of Four Active Site-directed 
Inhibitors
 1DWC_H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution 
Of The Binding To Human Thrombin Of Four Active Site-Directed 
Inhibitors
 1DWD_H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution 
Of The Binding To Human Thrombin Of Four Active Site-Directed 
Inhibitors
 1DWE_H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution 
Of The Binding To Human Thrombin Of Four Active Site-Directed 
Inhibitors
 1FPH_H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural 
Basis For Its Specificity
 1HGT_H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of 
Alpha- Thrombin
 1IHS_H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin 
And Non- Hydrolyzable Bifunctional Inhibitors, Hirutonin-2 
And Hirutonin-6
 1IHT_H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin 
And Non- Hydrolyzable Bifunctional Inhibitors, Hirutonin-2 
And Hirutonin-6
 1PPB_H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human 
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg Chloromethylketone 
And Significance Of The Tyr-Pro-Pro-Trp Insertion Segment
 1THR_H Chain H, Structures Of Thrombin Complexes With A Designed And 
A Natural Exosite Inhibitor
 1THS_H Chain H, Structures Of Thrombin Complexes With A Designed And 
A Natural Exosite Inhibitor
 1TMB_H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin 
By The Macrocyclic Peptide Cyclotheonamide A
 2HGT_H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of 
Alpha-thrombin
 2HPP_H Chain H, Structures Of The Noncovalent Complexes Of Human And 
Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin
 2HPQ_H Chain H, Structures Of The Noncovalent Complexes Of Human And 
Bovine Prothrombin Fragment 2 With Human Ppack-thrombin
 3HTC_H Chain H, The Structure Of A Complex Of Recombinant Hirudin And 
Human Alpha-Thrombin
 4HTC_H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
 1HUT_H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer 
Single-Stranded Dna Aptamer
 1NRN_H Chain H, Crystallographic Structures Of Thrombin Complexed With 
Thrombin Receptor Peptides: Existence Of Expected And Novel 
Binding Modes
 1NRO_H Chain H, Crystallographic Structures Of Thrombin Complexed With 
Thrombin Receptor Peptides: Existence Of Expected And Novel 
Binding Modes
 1NRP_H Chain H, Crystallographic Structures Of Thrombin Complexed With 
Thrombin Receptor Peptides: Existence Of Expected And Novel 
Binding Modes
 1NRQ_H Chain H, Crystallographic Structures Of Thrombin Complexed With 
Thrombin Receptor Peptides: Existence Of Expected And Novel 
Binding Modes
 1NRR_H Chain H, Crystallographic Structures Of Thrombin Complexed With 
Thrombin Receptor Peptides: Existence Of Expected And Novel 
Binding Modes
 1NRS_H Chain H, Crystallographic Structures Of Thrombin Complexed With 
Thrombin Receptor Peptides: Existence Of Expected And Novel 
Binding Modes
 1TMT_H Chain H, Changes In Interactions In Complexes Of Hirudin Derivatives 
And Human Alpha-thrombin Due To Different Crystal Forms
 1TMU_H Chain H, Changes In Interactions In Complexes Of Hirudin Derivatives 
And Human Alpha-Thrombin Due To Different Crystal Forms
 1HLT_H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf 
Domain Of Thrombomodulin Complexed With Thrombin
 1HLT_K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf 
Domain Of Thrombomodulin Complexed With Thrombin
 1HAH_H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And 
Ppack- Thrombin: Changes Accompanying Activation And Exosite 
Binding To Thrombin
 1HAI_H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And 
Ppack- Thrombin: Changes Accompanying Activation And Exosite 
Binding To Thrombin
 3HAT_H Chain H, Active Site Mimetic Inhibition Of Thrombin
 1FPC_H Chain H, Active Site Mimetic Inhibition Of Thrombin
 1HBT_H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium 
Methyl Ketone Containing Bivalent Inhibitor
 1HDT_H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed 
With Human Alpha-Thrombin
 1HAO_H Chain H, Complex Of Human Alpha-thrombin With A 15mer Oligonucleotide 
Ggttggtgtggttgg (based On Nmr Model Of Dna)
 1HAP_H Chain H, Complex Of Human Alpha-Thrombin With A 15mer Oligonucleotide 
Ggttggtgtggttgg (Based On X-Ray Model Of Dna)
 1AHT_H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed 
With Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms Resolution
 1DIT_H Chain H, Complex Of A Divalent Inhibitor With Thrombin
 1TOM_H Chain H, Alpha-Thrombin Complexed With Hirugen
 1HXF_H Chain H, Human Thrombin Complex With Hirudin Variant
 1BMM_H Chain H, Human Alpha-Thrombin Complexed With [s-(R,R)]-4-[(Aminoiminomethyl) 
Amino]-N-[[1-[3-Hydroxy-2-[(2-Naphthalenylsulfonyl)amino]-1- 
Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide 
(Bms-186282)
 1BMN_H Chain H, Human Alpha-Thrombin Complexed With [s-(R,R)]-1-(Aminoiminomethyl)- 
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-Pyrrolidinyl]methyl]-3- 
Piperidenecarboxamide (Bms-189090)
 1UMA_H Chain H, Alpha-Thrombin (Hirugen) Complexed With Na-(N,N-Dimethylcarbamoyl)- 
Alpha-Azalysine
 1LHD_H Chain H, Human Alpha-thrombin Complexed With Ac-(d)phe-pro-borolys-oh
 1LHE_H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N- 
Butyl-Amidino-Glycine-Oh
 1LHF_H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro- 
Homolys-Oh
 1LHG_H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro- Boroornithine-Oh
 1LHC_H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boroarg-Oh
 1AD8_H Chain H, Complex Of Thrombin With And Inhibitor Containing A 
Novel P1 Moiety
 1AI8_H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite 
Inhibitor Hirugen And Active Site Inhibitor Phch2oco-D-Dpa-Pro-Borompg
 1AIX_H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite Inhibitor 
Hirugen And Active Site Inhibitor Phch2oco-D-Dpa-Pro-Boroval
 1AE8_H Chain H, Human Alpha-Thrombin Inhibition By Eoc-D-Phe-Pro-Azalys-Onp
 1AFE_H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
 1UVS_H Chain H, Bovine Thrombin--Bm51.1011 Complex
 5GDS_H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure 
Of Human Alpha-Thrombin:hirunorm V Complex
 1AY6_H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based 
Macrocyclic Tripeptide Motif
 1A46_H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic 
Inhibitor
 1A4W_H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing 
Inhibitors: Probes Of The S1' Binding Site
 1A5G_H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide 
Mimetic Inhibitor And Hirugen
 1B5G_H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide 
Mimetic Inhibitor And Hirugen
 1TBZ_H Chain H, Human Thrombin With Active Site N-Methyl-D Phenylalanyl-N-[5- 
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl] 
Butyl]-L- Prolinamide Trifluroacetate And Exosite-Hirugen
 1A2C_H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-a 
From A Blue-green Alga
 1A61_H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing 
Inhibitor
 1A3B_H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional 
Boronate Inhibitor Borolog1
 1A3E_H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional 
Boronate Inhibitor Borolog2
 1AWF_H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
 1AWH_B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
 1AWH_D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
 1BCU_H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
 8KME_2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited 
With Sel2770.
 1BA8_B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
 1BB0_B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
 1CA8_B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
 4THN_H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv 
Complex Reveals A Novel Specificity Site Recognition Mode.
 1QBV_H Chain H, Crystal Structure Of Thrombin Complexed With An Guanidine-Mimetic 
Inhibitor
 1D4P_B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex 
With 5- Amidinoindole-4-benzylpiperidine Inhibitor
 7KME_H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited 
With Sel2711.
 1QHR_B Chain B, Novel Covalent Active Site Thrombin Inhibitors
 1QJ1_B Chain B, Novel Covalent Active Site Thrombin Inhibitors
 1QJ6_B Chain B, Novel Covalent Active Site Thrombin Inhibitors
 1QJ7_B Chain B, Novel Covalent Active Site Thrombin Inhibitors
 1D3P_B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex 
With Benzo[b]thiophene Inhibitor 3
 1D3Q_B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex 
With Benzo[b]thiophene Inhibitor 2
 1D3T_B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex 
With Benzo[b]thiophene Inhibitor 1
 1C4U_2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With 
Cyclohexyl Moieties.
 1C4V_2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With 
Cyclohexyl Moieties.
 1C4Y_2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
 1DE7_H Chain H, Interaction Of Factor Xiii Activation Peptide With Alpha-Thrombin: 
Crystal Structure Of The Enzyme-Substrate Complex
 1DE7_K Chain K, Interaction Of Factor Xiii Activation Peptide With Alpha-Thrombin: 
Crystal Structure Of The Enzyme-Substrate Complex
 1G30_B Chain B, Thrombin Inhibitor Complex
 1G32_B Chain B, Thrombin Inhibitor Complex
 1KTS_B Chain B, Thrombin Inhibitor Complex
 1KTT_B Chain B, Thrombin Inhibitor Complex
 1K21_H Chain H, Human Thrombin-Inhibitor Complex
 1K22_H Chain H, Human Thrombin-inhibitor Complex
 1NY2_2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
 1O2G_H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1OYT_H Chain H, Complex Of Recombinant Human Thrombin With A Designed 
Fluorinated Inhibitor
 1NO9_H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating 
Novel P1 Binding Functions: Molecular And X-Ray Crystallographic 
Studies.
 1OOK_B Chain B, Crystal Structure Of The Complex Of Platelet Receptor 
Gpib-alpha And Human Alpha-thrombin
 1P8V_C Chain C, Crystal Structure Of The Complex Of Platelet Receptor 
Gpib-alpha And Alpha-thrombin At 2.6a
 1NU7_B Chain B, Staphylocoagulase-Thrombin Complex
 1NU7_F Chain F, Staphylocoagulase-Thrombin Complex
 1NZQ_H Chain H, D-phe-pro-arg-type Thrombin Inhibitor
 1O0D_H Chain H, Human Thrombin Complexed With A D-phe-pro-arg-type Inhibitor 
And A C- Terminal Hirudin Derived Exo-site Inhibitor
 1MU6_B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
 1MU8_B Chain B, Thrombin-hirugen_l-378,650
 1MUE_B Chain B, Thrombin-Hirugen-L405,426
 1SR5_C Chain C, Antithrombin-anhydrothrombin-heparin Ternary Complex 
Structure
 1O5G_H Chain H, Dissecting And Designing Inhibitor Selectivity Determinants 
At The S1 Site Using An Artificial Ala190 Protease (Ala190 
Upa)
 1XMN_B Chain B, Crystal Structure Of Thrombin Bound To Heparin
 1XMN_D Chain D, Crystal Structure Of Thrombin Bound To Heparin
 1XMN_F Chain F, Crystal Structure Of Thrombin Bound To Heparin
 1XMN_H Chain H, Crystal Structure Of Thrombin Bound To Heparin
 1WAY_B Chain B, Active Site Thrombin Inhibitors
 1T4U_H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound 
To Thrombin
 1T4V_H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound 
To Thrombin
 2AFQ_B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin 
In The Sodium Free State
 2AFQ_D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin 
In The Sodium Free State
 2A45_B Chain B, Crystal Structure Of The Complex Between Thrombin And 
The Central "e" Region Of Fibrin
 2A45_E Chain E, Crystal Structure Of The Complex Between Thrombin And 
The Central "e" Region Of Fibrin
 1W7G_H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues 
54-65) And L- Arginine Template Inhibitor Cs107
 2FES_H Chain H, Orally Active Thrombin Inhibitors
 2C8W_B Chain B, Thrombin Inhibitors
 2C8X_B Chain B, Thrombin Inhibitors
 2C8Y_B Chain B, Thrombin Inhibitors
 2C8Z_B Chain B, Thrombin Inhibitors
 2C90_B Chain B, Thrombin Inhibitors
 2C93_B Chain B, Thrombin Inhibitors
 2FEQ_H Chain H, Orally Active Thrombin Inhibitors
 2BVS_H Chain H, Human Thrombin Complexed With Fragment-Based Small Molecules 
Occupying The S1 Pocket
 2BVX_H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors 
With A Solubilizing Cationic P1-P2-Linker
 2BXT_H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors 
With A Solubilizing Cationic P1-p2-linker
 2BXU_H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors 
With A Solubilizing Cationic P1-p2-linker
 2A2X_H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin 
Inh12
 2ANK_H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin 
And An Exosite Decapeptide
 2GDE_H Chain H, Thrombin In Complex With Inhibitor
 2H9T_H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex 
With Suramin
 2JH0_D Chain D, Human Thrombin Hirugen Inhibitor Complex
 2JH5_D Chain D, Human Thrombin Hirugen Inhibitor Complex
 2JH6_D Chain D, Human Thrombin Hirugen Inhibitor Complex
 1C1U_H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 1C1V_H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 1C1W_H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 1C5L_H Chain H, Structural Basis For Selectivity Of A Small Molecule, 
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type Plasminogen 
Activator
 1C5N_H Chain H, Structural Basis For Selectivity Of A Small Molecule, 
S1-binding, Sub- Micromolar Inhibitor Of Urokinase Type Plasminogen 
Activator
 1C5O_H Chain H, Structural Basis For Selectivity Of A Small Molecule, 
S1-binding, Sub- Micromolar Inhibitor Of Urokinase Type Plasminogen 
Activator
 1HXE_H Chain H, Serine Protease
 2UUF_B Chain B, Thrombin-hirugen Binary Complex At 1.26a Resolution
 2UUJ_B Chain B, Thrombin-hirugen-gw473178 Ternary Complex At 1.32a Resolution
 2UUK_B Chain B, Thrombin-hirugen-gw420128 Ternary Complex At 1.39a Resolution
 3BF6_H Chain H, Thrombin:suramin Complex
 2R2M_B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin 
Inhibitors
 3EGK_H Chain H, Knoble Inhibitor
 2ZC9_H Chain H, Thrombin In Complex With Inhibitor
 2ZDA_H Chain H, Exploring Thrombin S1 Pocket
 2ZDV_H Chain H, Exploring Thrombin S1 Pocket
 2ZF0_H Chain H, Exploring Thrombin S1 Pocket
 3E6P_H Chain H, Crystal Structure Of Human Meizothrombin Desf1
 2ZFF_H Chain H, Exploring Thrombin S1-pocket
 2ZFP_H Chain H, Thrombin Inibition
 2ZGB_H Chain H, Thrombin Inhibition
 2ZGX_H Chain H, Thrombin Inhibition
 2ZFQ_H Chain H, Exploring Thrombin S3 Pocket
 2ZFR_H Chain H, Exploring Thrombin S3 Pocket
 2ZHQ_H Chain H, Thrombin Inhibition
 2ZI2_H Chain H, Thrombin Inhibition
 2ZIQ_H Chain H, Thrombin Inhibition
 2ZG0_H Chain H, Exploring Thrombin S3 Pocket
 2ZHE_H Chain H, Exploring Thrombin S3 Pocket
 2ZHF_H Chain H, Exploring Thrombin S3 Pocket
 2ZHW_H Chain H, Exploring Thrombin S3 Pocket
 3C27_B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin 
Inhibitors
 2ZNK_H Chain H, Thrombin Inhibition
 2ZO3_H Chain H, Bisphenylic Thrombin Inhibitors
 3D49_H Chain H, Thrombin Inhibition
 3DA9_B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
 3DHK_H Chain H, Bisphenylic Thrombin Inhibitors
 3DT0_H Chain H, Understanding Thrombin Inhibition
 3DUX_H Chain H, Understanding Thrombin Inhibition
 3EQ0_H Chain H, Thrombin Inhibitor
 3F68_H Chain H, Thrombin Inhibition
 3PMH_B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib 
Interaction With Two Distinct Alpha-Thrombin Sites
 3P6Z_B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation: 
Essential Role Of The Hirudin-Like Sequence Glu666-Glu672 
For Processing At The Heavy Chain-B Domain Junction
 3P6Z_H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation: 
Essential Role Of The Hirudin-Like Sequence Glu666-Glu672 
For Processing At The Heavy Chain-B Domain Junction
 3LDX_H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A Thrombin 
Inhibitor With An Oxyguanidine P1 Motif
 3P70_B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation: 
Essential Role Of The Hirudin-Like Sequence Glu666-Glu672 
For Processing At The Heavy Chain-B Domain Junction
 3P70_D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation: 
Essential Role Of The Hirudin-Like Sequence Glu666-Glu672 
For Processing At The Heavy Chain-B Domain Junction
 3P70_F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation: 
Essential Role Of The Hirudin-Like Sequence Glu666-Glu672 
For Processing At The Heavy Chain-B Domain Junction
 3P70_H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation: 
Essential Role Of The Hirudin-Like Sequence Glu666-Glu672 
For Processing At The Heavy Chain-B Domain Junction
 3TU7_H Chain H, Human Alpha-Thrombin Complexed With N-(Methylsulfonyl)-D-Phenylalanyl- 
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide 
(Bms-189664)
 3QLP_H Chain H, X-Ray Structure Of The Complex Between Human Alpha Thrombin 
And A Modified Thrombin Binding Aptamer (Mtba)
 3P17_H Chain H, Thrombin Inhibition By Pyridin Derivatives
 3B23_B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights 
Of A Novel Mechanism Of Inhibition And Design Of Tunable 
Thrombin Inhibitors
 3QTO_H Chain H, Thrombin Inhibition By Pyridin Derivatives
 3QTV_H Chain H, Thrombin Inhibition By Pyridin Derivatives
 3QX5_H Chain H, Thrombin Inhibition By Pyridin Derivatives
 3QWC_H Chain H, Thrombin Inhibition By Pyridin Derivatives
 3U69_H Chain H, Unliganded Wild-Type Human Thrombin
 3U8T_H Chain H, Human Thrombin Complexed With D-phe-pro-d-arg-cys
 3RLW_H Chain H, Human Thrombin In Complex With Mi328
 3RLY_H Chain H, Human Thrombin In Complex With Mi329
 3RM0_H Chain H, Human Thrombin In Complex With Mi354
 3RM2_H Chain H, Human Thrombin In Complex With Mi003
 3RML_H Chain H, Human Thrombin In Complex With Mi331
 3RMM_H Chain H, Human Thrombin In Complex With Mi332
 3RMN_H Chain H, Human Thrombin In Complex With Mi341
 3RMO_H Chain H, Human Thrombin In Complex With Mi004
 3U8O_H Chain H, Human Thrombin Complexed With D-phe-pro-d-arg-d-thr
 3U8R_H Chain H, Human Thrombin Complexed With D-phe-pro-d-arg-ile
 3SHA_H Chain H, Human Thrombin In Complex With Ubthr97
 3SHC_H Chain H, Human Thrombin In Complex With Ubthr101
 3SI3_H Chain H, Human Thrombin In Complex With Ubthr103
 3SI4_H Chain H, Human Thrombin In Complex With Ubthr104
 3SV2_H Chain H, Human Thrombin In Complex With Ubthr105
 4E7R_H Chain H, Thrombin In Complex With 3-amidinophenylalanine Inhibitor
 4E7R_G Chain G, Thrombin In Complex With 3-amidinophenylalanine Inhibitor
 4DIH_H Chain H, X-Ray Structure Of The Complex Between Human Alpha Thrombin 
And Thrombin Binding Aptamer In The Presence Of Sodium 
Ions
 4DII_H Chain H, X-Ray Structure Of The Complex Between Human Alpha Thrombin 
And Thrombin Binding Aptamer In The Presence Of Potassium 
Ions
 3T5F_H Chain H, Human Thrombin In Complex With Mi340
 3UTU_H Chain H, High Affinity Inhibitor Of Human Thrombin
 3U98_H Chain H, Human Thrombin In Complex With Mi001
 3U9A_H Chain H, Human Thrombin In Complex With Mi330
 4E05_H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin 
Through A Novel Reverse-Binding Mechanism
 4E06_H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin 
Through A Novel Reverse-Binding Mechanism
 3UWJ_H Chain H, Human Thrombin In Complex With Mi353
 4BAH_B Chain B, Thrombin In Complex With Inhibitor
 4BAK_B Chain B, Thrombin In Complex With Inhibitor
 4BAM_B Chain B, Thrombin In Complex With Inhibitor
 4BAN_B Chain B, Thrombin In Complex With Inhibitor
 4BAO_B Chain B, Thrombin In Complex With Inhibitor
 4BAQ_B Chain B, Thrombin In Complex With Inhibitor
 3VXE_H Chain H, Human Alpha-thrombin-bivalirudin Complex At Pd5.0
 4BOH_A Chain A, Madanins (merops I53) Are Cleaved By Thrombin And Factor 
Xa
 4BOH_H Chain H, Madanins (merops I53) Are Cleaved By Thrombin And Factor 
Xa
 4I7Y_H Chain H, Crystal Structure Of Human Alpha Thrombin In Complex 
With A 27-mer Aptamer Bound To Exosite Ii
 4N3L_H Chain H, Crystal Structure Of Thrombin In Complex With A Novel 
Glucose- Conjugated Potent Inhibitor
 4CH2_B Chain B, Low-salt Crystal Structure Of A Thrombin-gpibalpha Peptide 
Complex
 4CH2_D Chain D, Low-salt Crystal Structure Of A Thrombin-gpibalpha Peptide 
Complex
 4CH8_B Chain B, High-salt Crystal Structure Of A Thrombin-gpibalpha 
Peptide Complex
 4CH8_D Chain D, High-salt Crystal Structure Of A Thrombin-gpibalpha 
Peptide Complex
 4CH8_F Chain F, High-salt Crystal Structure Of A Thrombin-gpibalpha 
Peptide Complex
 4CH8_H Chain H, High-salt Crystal Structure Of A Thrombin-gpibalpha 
Peptide Complex
 4LZ1_H Chain H, X-ray Structure Of The Complex Between Human Thrombin 
And The Tba Deletion Mutant Lacking Thymine 12 Nucleobase
 4LZ4_B Chain B, X-ray Structure Of The Complex Between Human Thrombin 
And The Tba Deletion Mutant Lacking Thymine 3 Nucleobase
 4LZ4_D Chain D, X-ray Structure Of The Complex Between Human Thrombin 
And The Tba Deletion Mutant Lacking Thymine 3 Nucleobase
 4NZE_H Chain H, Crystal Structure Of Thrombin In Complex With A Novel 
Tetra-o-acetyl- Glucopyranoside-conjugated Potent Inhibitor
 4LXB_H Chain H, Crystal Structure Analysis Of Thrombin In Complex With 
Compound D58
 4YES_B Chain B, Thrombin In Complex With (s)-(4-chloro-2-((1-(5-methyl-1h-pyrrole-2- 
Carbonyl)pyrrolidine-2-carboxamido)methyl)phenyl)methanaminium
 4UD9_H Chain H, Thrombin In Complex With 5-chlorothiophene-2-carboxamide
 5E8E_H Chain H, Crystal Structure Of Thrombin Bound To An Exosite 1-specific 
Iga Fab
 5CMX_H Chain H, X-ray Structure Of The Complex Between Human Alpha Thrombin 
And A Duplex/quadruplex 31-mer Dna Aptamer
 5LUY_H Chain H, X-ray Structure Of The Complex Between Human Alpha-thrombin 
And Modified 15-mer Dna Aptamer Containing 5-(3-(acetamide-n-yl)-1- 
Propen-1-yl)-2'-deoxyuridine Residue
 5LUW_H Chain H, X-ray Structure Of The Complex Between Human Alpha-thrombin 
And Modified 15-mer Dna Aptamer Containing 5-(3-(2-(1h-indol-3-yl) 
Acetamide-n-yl)-1-propen-1-yl)-2'-deoxyuridine 
Residue
Length=259

 Score = 370 bits (951),  Expect = 4e-131, Method: Compositional matrix adjust.
 Identities = 162/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  258


>1D9I_A Chain A, Structure Of Thrombin Complexed With Selective Non-Electophilic 
Inhibitors Having Cyclohexyl Moieties At P1
Length=288

 Score = 371 bits (953),  Expect = 5e-131, Method: Compositional matrix adjust.
 Identities = 162/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  54   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  113

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  114  IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  173

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  174  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  233

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  234  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  288


>2BDY_A Chain A, Thrombin In Complex With Inhibitor
Length=289

 Score = 371 bits (953),  Expect = 5e-131, Method: Compositional matrix adjust.
 Identities = 162/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  54   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  113

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  114  IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  173

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  174  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  233

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  234  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  288


>1NU9_A Chain A, Staphylocoagulase-prethrombin-2 Complex
 1NU9_D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length=291

 Score = 371 bits (953),  Expect = 5e-131, Method: Compositional matrix adjust.
 Identities = 162/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  56   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  115

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  116  IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  175

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  176  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  235

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  236  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  290


>1NM6_A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor 
At 1.8a
 1NT1_A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
 1TA2_A Chain A, Crystal Structure Of Thrombin In Complex With Compound 
1
 1TA6_A Chain A, Crystal Structure Of Thrombin In Complex With Compound 
14b
 1SL3_A Chain A, Crystal Structue Of Thrombin In Complex With A Potent 
P1 Heterocycle- Aryl Based Inhibitor
 1Z71_A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex Structure
 1ZRB_A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
 1ZGI_A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 
21
 1ZGV_A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 
2
 3C1K_A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 
15
Length=287

 Score = 371 bits (952),  Expect = 7e-131, Method: Compositional matrix adjust.
 Identities = 162/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  53   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  112

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  113  IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  172

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  173  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  232

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  233  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  287


>1HAG_E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And 
Ppack- Thrombin: Changes Accompanying Activation And Exosite 
Binding To Thrombin
 1DOJ_A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex 
At 1.7 A
 1XM1_A Chain A, Nonbasic Thrombin Inhibitor Complex
Length=295

 Score = 371 bits (953),  Expect = 7e-131, Method: Compositional matrix adjust.
 Identities = 162/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  60   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  119

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  120  IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  179

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  180  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  239

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  240  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  294


>3R3G_B Chain B, Structure Of Human Thrombin With Residues 145-150 Of 
Murine Thrombin.
Length=259

 Score = 370 bits (949),  Expect = 7e-131, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSSPKSL-PTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++   + P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LRETWTTNINEIQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  258


>4H6S_B Chain B, Crystal Structure Of Thrombin Mutant E14ea/d14la/e18a/s195a
Length=259

 Score = 370 bits (949),  Expect = 9e-131, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            D+GGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  258


>1DM4_B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With Fibrinopeptide 
A (7- 16)
 1JMO_H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a Thrombin 
Complex
Length=260

 Score = 369 bits (948),  Expect = 1e-130, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  25   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  84

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  85   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  144

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  145  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  204

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            D+GGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  205  DAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  259


>1JOU_B Chain B, Crystal Structure Of Native S195a Thrombin With An Unoccupied 
Active Site
 1JOU_D Chain D, Crystal Structure Of Native S195a Thrombin With An Unoccupied 
Active Site
 1JOU_F Chain F, Crystal Structure Of Native S195a Thrombin With An Unoccupied 
Active Site
 1TB6_H Chain H, 2.5a Crystal Structure Of The Antithrombin-Thrombin-Heparin 
Ternary Complex
 2B5T_B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between 
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two 
S195a Thrombin Molecules
 2B5T_D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between 
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two 
S195a Thrombin Molecules
 3B9F_H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
 3GIS_B Chain B, Crystal Structure Of Na-free Thrombin In Complex With 
Thrombomodulin
 3GIS_D Chain D, Crystal Structure Of Na-free Thrombin In Complex With 
Thrombomodulin
 3GIS_F Chain F, Crystal Structure Of Na-free Thrombin In Complex With 
Thrombomodulin
 3LU9_B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In 
Complex Extracellular Fragment Of Human Par1
 3LU9_E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In 
Complex Extracellular Fragment Of Human Par1
 4DT7_B Chain B, Crystal Structure Of Thrombin Bound To The Activation 
Domain Qedqvdprlidgkmtrrgds Of Protein C
 4DT7_D Chain D, Crystal Structure Of Thrombin Bound To The Activation 
Domain Qedqvdprlidgkmtrrgds Of Protein C
 4DY7_B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With 
S195a Thrombin
 4DY7_E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With 
S195a Thrombin
 4HFP_B Chain B, Structure Of Thrombin Mutant S195a Bound To The Active 
Site Inhibitor Argatroban
 4HFP_D Chain D, Structure Of Thrombin Mutant S195a Bound To The Active 
Site Inhibitor Argatroban
Length=259

 Score = 369 bits (948),  Expect = 1e-130, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            D+GGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  258


>1SFQ_B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
 1SFQ_E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
 1SG8_B Chain B, Crystal Structure Of The Procoagulant Fast Form Of Thrombin
 1SG8_E Chain E, Crystal Structure Of The Procoagulant Fast Form Of Thrombin
 1SGI_B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of 
Thrombin
 1SGI_E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of 
Thrombin
 1SHH_B Chain B, Slow Form Of Thrombin Bound With Ppack
 1SHH_E Chain E, Slow Form Of Thrombin Bound With Ppack
 2HWL_B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen 
Gamma' Peptide
 2HWL_D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen 
Gamma' Peptide
 3BV9_B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length=259

 Score = 369 bits (948),  Expect = 1e-130, Method: Compositional matrix adjust.
 Identities = 162/235 (69%), Positives = 207/235 (88%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E   EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYEANIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  258


>4H6T_A Chain A, Crystal Structure Of Prethrombin-2 Mutant E14ea/d14la/e18a/s195a
Length=306

 Score = 371 bits (953),  Expect = 1e-130, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  71   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  130

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  131  IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  190

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  191  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  250

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            D+GGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  251  DAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  305


>4RKJ_B Chain B, Crystal Structure Of Thrombin Mutant S195t (free Form)
 4RKO_B Chain B, Crystal Structure Of Thrombin Mutant S195t Bound With 
Ppack
Length=259

 Score = 369 bits (948),  Expect = 1e-130, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            D+GGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DTGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  258


>1BTH_H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic 
Trypsin Inhibitor
 1BTH_K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic 
Trypsin Inhibitor
Length=259

 Score = 369 bits (948),  Expect = 1e-130, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDAC+G
Sbjct  144  LKETWTTNVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACQG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  258


>3SQE_E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The 
Alternative Form
 3SQH_E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The 
The Open Form
 4RN6_A Chain A, Structure Of Prethrombin-2 Mutant S195a Bound To The 
Active Site Inhibitor Argatroban
 4RN6_B Chain B, Structure Of Prethrombin-2 Mutant S195a Bound To The 
Active Site Inhibitor Argatroban
Length=290

 Score = 370 bits (951),  Expect = 1e-130, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  55   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  114

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  115  IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  174

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  175  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  234

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            D+GGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  235  DAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  289


>1QUR_H Chain H, Human Alpha-Thrombin In Complex With Bivalent, Benzamidine-Based 
Synthetic Inhibitor
 1D3D_B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex 
With Benzothiophene Inhibitor 4
 1EB1_H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine 
Inhibitor
 1GHV_H Chain H, A Novel Serine Protease Inhibition Motif Involving A 
Multi-Centered Short Hydrogen Bonding Network At The Active 
Site
 1YPE_H Chain H, Thrombin Inhibitor Complex
 1YPG_H Chain H, Thrombin Inhibitor Complex
 1YPJ_H Chain H, Thrombin Inhibitor Complex
 1YPK_H Chain H, Thrombin Inhibitor Complex
 1YPL_H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic 
Cyanopeptide Analogue Ra-1008
 1YPM_H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic 
Cyanopeptide Analogue Ra-1014
 2ANM_H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor 
With Human Thrombin And A C-Terminal Hirudin Derived Exo-Sit 
Inhibitor
 2CF9_H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
 1GHX_H Chain H, A Novel Serine Protease Inhibition Motif Involving A 
Multi-Centered Short Hydrogen Bonding Network At The Active 
Site
 1GHY_H Chain H, A Novel Serine Protease Inhibition Motif Involving A 
Multi-Centered Short Hydrogen Bonding Network At The Active 
Site
 2CF8_H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
 2CN0_H Chain H, Complex Of Recombinant Human Thrombin With A Designed 
Inhibitor
 3BIU_H Chain H, Human Thrombin-in Complex With Ub-thr10
 3BIV_H Chain H, Human Thrombin-In Complex With Ub-Thr11
 2V3H_H Chain H, Thrombin With 3-cycle No F
 2V3O_H Chain H, Thrombin With 3-cycle With F
 4AX9_H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
 4AYV_B Chain B, Human Thrombin - Inhibitor Complex
 4AYY_B Chain B, Human Thrombin - Inhibitor Complex
 4AZ2_B Chain B, Human Thrombin - Inhibitor Complex
 1GHW_H Chain H, A Novel Serine Protease Inhibition Motif Involving A 
Multi-centered Short Hydrogen Bonding Network At The Active 
Site
 4LOY_H Chain H, Crystal Structure Analysis Of Thrombin In Complex With 
Compound D57, 5-chlorothiophene-2-carboxylic Acid [(s)-2-[2-methyl-3-(2- 
Oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1- 
Yl)- 3-oxopropyl]amide (sar107375)
Length=257

 Score = 369 bits (947),  Expect = 1e-130, Method: Compositional matrix adjust.
 Identities = 161/233 (69%), Positives = 207/233 (89%), Gaps = 1/233 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDK  232
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQ  256


>3K65_B Chain B, Crystal Structure Of Prethombin-2/fragment-2 Complex
Length=308

 Score = 371 bits (952),  Expect = 1e-130, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  73   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  132

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  133  IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  192

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  193  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  252

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            D+GGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  253  DAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  307


>2THF_B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound 
To D-phe-pro-arg- Chloromethylketone
Length=259

 Score = 369 bits (947),  Expect = 2e-130, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGK+GFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKFGFYTHVFRLKKWIQKVIDQFG  258


>1RD3_B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
 1RD3_D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length=259

 Score = 369 bits (947),  Expect = 2e-130, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWG+GCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGKGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  258


>1BBR_K Chain K, The Structure Of Residues 7-16 Of The A Alpha Chain 
Of Human Fibrinogen Bound To Bovine Thrombin At 2.3 Angstroms 
Resolution
 1BBR_N Chain N, The Structure Of Residues 7-16 Of The A Alpha Chain 
Of Human Fibrinogen Bound To Bovine Thrombin At 2.3 Angstroms 
Resolution
 1ETR_H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine 
Thrombin Complexes Formed With The Benzamidine And Arginine-Based 
Thrombin Inhibitors Napap, 4-Tapap And Mqpa: A Starting 
Point For Improving Antithrombotics
 1ETS_H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine 
Thrombin Complexes Formed With The Benzamidine And Arginine-Based 
Thrombin Inhibitors Napap, 4-Tapap And Mqpa: A Starting 
Point For Improving Antithrombotics
 1ETT_H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine 
Thrombin Complexes Formed With The Benzamidine And Arginine-Based 
Thrombin Inhibitors Napap, 4-Tapap And Mqpa: A Starting 
Point For Improving Antithrombotics
 1HRT_H Chain H, The Structure Of A Complex Of Bovine Alpha-Thrombin 
And Recombinant Hirudin At 2.8 Angstroms Resolution
 1TBR_H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal 
Inhibitor Rhodniin In Complex With Thrombin
 1TBR_K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal 
Inhibitor Rhodniin In Complex With Thrombin
 1TBQ_H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal 
Inhibitor Rhodniin In Complex With Thrombin
 1TBQ_K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal 
Inhibitor Rhodniin In Complex With Thrombin
 1UCY_K Chain K, Thrombin Complexed With Fibrinopeptide A Alpha (Residues 
7- 19). Three Complexes, One With Epsilon-Thrombin And 
Two With Alpha-Thrombin
 1UCY_N Chain N, Thrombin Complexed With Fibrinopeptide A Alpha (Residues 
7- 19). Three Complexes, One With Epsilon-Thrombin And 
Two With Alpha-Thrombin
 1VIT_H Chain H, Thrombin:hirudin 51-65 Complex
 1MKW_H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha- 
Thrombin And Prethrombin-2: Movement Of The Yppw Segment And 
Active Site Residues Upon Ligand Binding
 1MKX_H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha- 
Thrombin And Prethrombin-2: Movement Of The Yppw Segment And 
Active Site Residues Upon Ligand Binding
 1TOC_B Chain B, Structure Of Serine Proteinase
 1TOC_D Chain D, Structure Of Serine Proteinase
 1TOC_F Chain F, Structure Of Serine Proteinase
 1TOC_H Chain H, Structure Of Serine Proteinase
 1UVT_H Chain H, Bovine Thrombin--Bm14.1248 Complex
 1UVU_H Chain H, Bovine Thrombin--Bm12.1700 Complex
 1YCP_H Chain H, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 
(F8y) Bound To Bovine Thrombin Explains Why The Mutation Of 
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At Arginine-16
 1A0H_B Chain B, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1: 
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN INTERACTIONS 
AND Location Of The Linker Chain
 1A0H_E Chain E, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1: 
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN INTERACTIONS 
AND Location Of The Linker Chain
 1AVG_H Chain H, Thrombin Inhibitor From Triatoma Pallidipennis
 2A1D_B Chain B, Staphylocoagulase Bound To Bovine Thrombin
 2A1D_F Chain F, Staphylocoagulase Bound To Bovine Thrombin
 2ODY_B Chain B, Thrombin-bound Boophilin Displays A Functional And Accessible 
Reactive-site Loop
 2ODY_D Chain D, Thrombin-bound Boophilin Displays A Functional And Accessible 
Reactive-site Loop
 3PMA_B Chain B, 2.2 Angstrom Crystal Structure Of The Complex Between 
Bovine Thrombin And Sucrose Octasulfate
 3PMA_D Chain D, 2.2 Angstrom Crystal Structure Of The Complex Between 
Bovine Thrombin And Sucrose Octasulfate
 3PMB_B Chain B, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In 
Tetragonal Spacegroup
 3PMB_D Chain D, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In 
Tetragonal Spacegroup
Length=259

 Score = 369 bits (947),  Expect = 2e-130, Method: Compositional matrix adjust.
 Identities = 163/235 (69%), Positives = 204/235 (87%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT++D+LVR+GKH+R ++E+  EKI  +D+
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLLVRIGKHSRTRYERKVEKISMLDK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNWKENL+RDIALL ++RPI  +D IHPVCLP KQ A  L+ AG+KGRVTGWGN
Sbjct  84   IYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWGN  143

Query  121  LYETWSSSPKSL-PTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
              ETW++S   + P+VLQ ++LP+VE+ +C+ ST IRITDNMFCAG+KP E K GDACEG
Sbjct  144  RRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIRITDNMFCAGYKPGEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDRLG  258


>2GP9_B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A 
Self- Inhibited Conformation
 3BEI_B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A 
Self_inhibited Conformation
 3BEF_B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular 
Fragment Of Par1
 3BEF_E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular 
Fragment Of Par1
 3QDZ_B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n 
In Complex With The Extracellular Fragment Of Human Par4.
 3QDZ_D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n 
In Complex With The Extracellular Fragment Of Human Par4.
 4MLF_B Chain B, Crystal Structure For The Complex Of Thrombin Mutant 
D102n And Hirudin
Length=259

 Score = 369 bits (947),  Expect = 2e-130, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+R+IAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRNIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  258


>1D6W_A Chain A, Structure Of Thrombin Complexed With Selective Non-Electrophilic 
Inhibitors Having Cyclohexyl Moieties At P1
 1G37_A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed 
With Bch-10556 And Exosite-directed Peptide
Length=287

 Score = 370 bits (949),  Expect = 2e-130, Method: Compositional matrix adjust.
 Identities = 161/233 (69%), Positives = 207/233 (89%), Gaps = 1/233 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  54   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  113

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  114  IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  173

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  174  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  233

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDK  232
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+
Sbjct  234  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQ  286


>1DX5_M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
 1DX5_N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
 1DX5_O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
 1DX5_P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
 1E0F_D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin 
Complex: An Exosite Ii-Binding Inhibitor
 1E0F_F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin 
Complex: An Exosite Ii-Binding Inhibitor
 1E0F_E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin 
Complex: An Exosite Ii-Binding Inhibitor
Length=259

 Score = 369 bits (946),  Expect = 2e-130, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 207/235 (88%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNF  ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFIENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  258


>1EOJ_A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin 
Inhibitors And Their Crystal Structures
 1EOL_A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin 
Inhibitors And Their Crystal Structures
Length=289

 Score = 370 bits (949),  Expect = 3e-130, Method: Compositional matrix adjust.
 Identities = 161/233 (69%), Positives = 207/233 (89%), Gaps = 1/233 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  56   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  115

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  116  IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  175

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  176  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  235

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDK  232
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+
Sbjct  236  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQ  288


>1Z8I_B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound 
To Ppack
Length=259

 Score = 369 bits (946),  Expect = 3e-130, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 207/235 (88%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACE 
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEA  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  258


>2A0Q_B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
 2A0Q_D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length=257

 Score = 368 bits (945),  Expect = 3e-130, Method: Compositional matrix adjust.
 Identities = 161/233 (69%), Positives = 206/233 (88%), Gaps = 1/233 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E   EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYEANIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDK  232
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQ  256


>5JDU_B Chain B, Crystal Structure For Human Thrombin Mutant D189a
 5JDU_D Chain D, Crystal Structure For Human Thrombin Mutant D189a
Length=259

 Score = 368 bits (944),  Expect = 4e-130, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 207/235 (88%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K G ACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGAACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  258


>1MH0_A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of 
Thrombin
 1MH0_B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of 
Thrombin
Length=287

 Score = 369 bits (946),  Expect = 5e-130, Method: Compositional matrix adjust.
 Identities = 161/233 (69%), Positives = 206/233 (88%), Gaps = 1/233 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E   EKI  +++
Sbjct  54   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYEANIEKISMLEK  113

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  114  IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  173

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  174  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  233

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDK  232
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+
Sbjct  234  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQ  286


>1MKW_K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha- 
Thrombin And Prethrombin-2: Movement Of The Yppw Segment And 
Active Site Residues Upon Ligand Binding
 1MKX_K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha- 
Thrombin And Prethrombin-2: Movement Of The Yppw Segment And 
Active Site Residues Upon Ligand Binding
Length=308

 Score = 369 bits (948),  Expect = 6e-130, Method: Compositional matrix adjust.
 Identities = 163/235 (69%), Positives = 204/235 (87%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT++D+LVR+GKH+R ++E+  EKI  +D+
Sbjct  73   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLLVRIGKHSRTRYERKVEKISMLDK  132

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNWKENL+RDIALL ++RPI  +D IHPVCLP KQ A  L+ AG+KGRVTGWGN
Sbjct  133  IYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWGN  192

Query  121  LYETWSSSPKSL-PTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
              ETW++S   + P+VLQ ++LP+VE+ +C+ ST IRITDNMFCAG+KP E K GDACEG
Sbjct  193  RRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIRITDNMFCAGYKPGEGKRGDACEG  252

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  253  DSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDRLG  307


>1B7X_B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound 
To D- Phe-Pro-Arg-Chloromethylketone
Length=259

 Score = 367 bits (943),  Expect = 7e-130, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 207/235 (88%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGK GFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKIGFYTHVFRLKKWIQKVIDQFG  258


>1Z8J_B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound 
To Ppack
Length=259

 Score = 367 bits (943),  Expect = 7e-130, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 207/235 (88%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACE 
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEP  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  258


>3JZ1_B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In 
E:na+ Form
 3JZ2_B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In 
E Form
 3QGN_B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of 
The Trypsin Fold
Length=259

 Score = 367 bits (942),  Expect = 8e-130, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 207/235 (88%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWG 
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGP  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  258


>1H8I_H Chain H, X-Ray Crystal Structure Of Human Alpha-Thrombin With 
A Tripeptide Phosphonate Inhibitor.
Length=253

 Score = 367 bits (941),  Expect = 9e-130, Method: Compositional matrix adjust.
 Identities = 161/234 (69%), Positives = 204/234 (87%), Gaps = 5/234 (2%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGD  180
            L ETW       P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEGD
Sbjct  144  LKETWGQ-----PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGD  198

Query  181  SGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            SGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  199  SGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  252


>1ID5_H Chain H, Crystal Structure Of Bovine Thrombin Complex With Protease 
Inhibitor Ecotin
Length=256

 Score = 367 bits (941),  Expect = 1e-129, Method: Compositional matrix adjust.
 Identities = 162/233 (70%), Positives = 203/233 (87%), Gaps = 1/233 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT++D+LVR+GKH+R ++E+  EKI  +D+
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLLVRIGKHSRTRYERKVEKISMLDK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNWKENL+RDIALL ++RPI  +D IHPVCLP KQ A  L+ AG+KGRVTGWGN
Sbjct  84   IYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWGN  143

Query  121  LYETWSSSPKSL-PTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
              ETW++S   + P+VLQ ++LP+VE+ +C+ ST IRITDNMFCAG+KP E K GDACEG
Sbjct  144  RRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIRITDNMFCAGYKPGEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDK  232
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+
Sbjct  204  DSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDR  256


>3NXP_A Chain A, Crystal Structure Of Human Prethrombin-1
Length=424

 Score = 373 bits (957),  Expect = 1e-129, Method: Compositional matrix adjust.
 Identities = 162/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  189  QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  248

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  249  IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  308

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  309  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  368

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  369  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  423


>1THP_B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound 
To D-Phe-Pro-Arg- Chloromethylketone
 3S7H_B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
 3S7K_B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
 3S7K_D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length=259

 Score = 367 bits (941),  Expect = 1e-129, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 207/235 (88%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGK GFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKPGFYTHVFRLKKWIQKVIDQFG  258


>1TWX_B Chain B, Crystal Structure Of The Thrombin Mutant D221a/d222k
Length=259

 Score = 365 bits (938),  Expect = 3e-129, Method: Compositional matrix adjust.
 Identities = 160/235 (68%), Positives = 206/235 (88%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGC R GKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCARKGKYGFYTHVFRLKKWIQKVIDQFG  258


>2PGB_B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
 2PGQ_B Chain B, Human Thrombin Mutant C191a-c220a In Complex With The 
Inhibitor Ppack
Length=259

 Score = 365 bits (937),  Expect = 5e-129, Method: Compositional matrix adjust.
 Identities = 160/235 (68%), Positives = 206/235 (88%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDA EG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDAAEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEG DRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGADRDGKYGFYTHVFRLKKWIQKVIDQFG  258


>1WBG_B Chain B, Active Site Thrombin Inhibitors
Length=259

 Score = 365 bits (936),  Expect = 7e-129, Method: Compositional matrix adjust.
 Identities = 160/235 (68%), Positives = 206/235 (88%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGC  DGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCRDDGKYGFYTHVFRLKKWIQKVIDQFG  258


>2OD3_B Chain B, Human Thrombin Chimera With Human Residues 184a, 186, 
186a, 186b, 186c And 222 Replaced By Murine Thrombin Equivalents.
Length=259

 Score = 365 bits (936),  Expect = 9e-129, Method: Compositional matrix adjust.
 Identities = 160/235 (68%), Positives = 205/235 (87%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAGFK  + K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGFKVNDTKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDR GKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKKWIQKVIDQFG  258


>3EE0_B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN 
Thrombin (Space Group P2(1)2(1)2(1))
 3HKJ_B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A 
IN COMPLEX WITH The Extracellular Fragment Of Human Par1
 3HKJ_E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A 
IN COMPLEX WITH The Extracellular Fragment Of Human Par1
Length=259

 Score = 365 bits (936),  Expect = 9e-129, Method: Compositional matrix adjust.
 Identities = 160/235 (68%), Positives = 206/235 (88%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVS G GCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSAGAGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  258


>2PUX_B Chain B, Crystal Structure Of Murine Thrombin In Complex With 
The Extracellular Fragment Of Murine Par3
 2PV9_B Chain B, Crystal Structure Of Murine Thrombin In Complex With 
The Extracellular Fragment Of Murine Par4
Length=258

 Score = 363 bits (933),  Expect = 2e-128, Method: Compositional matrix adjust.
 Identities = 162/235 (69%), Positives = 203/235 (86%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHCILYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLLVRIGKHSRTRYERNVEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I VHP+YNW+ENL+RDIALL +++P+ F+D IHPVCLP KQ   +L+ AGYKGRVTGWGN
Sbjct  84   IYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVCLPDKQTVTSLLRAGYKGRVTGWGN  143

Query  121  LYETWSSSPKSL-PTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++   + P+VLQ ++LPIVE+ +C+ ST IRITDNMFCAGFK  + K GDACEG
Sbjct  144  LRETWTTNINEIQPSVLQVVNLPIVERPVCKASTRIRITDNMFCAGFKVNDTKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            D+GGPFVMKSP +NRWYQ+GIVSWGEGCDR GKYGFYTH+FR++RW++KVID+ G
Sbjct  204  DAGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKRWIQKVIDQFG  258


>2BVR_H Chain H, Human Thrombin Complexed With Fragment-based Small Molecules 
Occupying The S1 Pocket
Length=252

 Score = 363 bits (931),  Expect = 3e-128, Method: Compositional matrix adjust.
 Identities = 160/234 (68%), Positives = 203/234 (87%), Gaps = 6/234 (3%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGD  180
            L E      K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEGD
Sbjct  144  LKE------KGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGD  197

Query  181  SGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            SGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  198  SGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  251


>1TQ0_B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin 
Mutant W215aE217A IN FREE FORM
 1TQ0_D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin 
Mutant W215aE217A IN FREE FORM
 1TQ7_B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant 
W215aE217A Bound To Ppack
Length=257

 Score = 363 bits (931),  Expect = 4e-128, Method: Compositional matrix adjust.
 Identities = 159/233 (68%), Positives = 205/233 (88%), Gaps = 1/233 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  144  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDK  232
            DSGGPFVMKSP +NRWYQ+GIVS G GCDRDGKYGFYTH+FR+++W++KVID+
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSAGAGCDRDGKYGFYTHVFRLKKWIQKVIDQ  256


>1H8D_H Chain H, X-Ray Structure Of The Human Alpha-Thrombin Complex 
With A Tripeptide Phosphonate Inhibitor.
Length=260

 Score = 363 bits (931),  Expect = 4e-128, Method: Compositional matrix adjust.
 Identities = 160/234 (68%), Positives = 203/234 (87%), Gaps = 6/234 (3%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGD  180
            L ET        P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEGD
Sbjct  144  LKET------GQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGD  197

Query  181  SGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            SGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  198  SGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  251


>2OCV_B Chain B, Structural Basis Of Na+ Activation Mimicry In Murine 
Thrombin
Length=259

 Score = 362 bits (930),  Expect = 6e-128, Method: Compositional matrix adjust.
 Identities = 162/235 (69%), Positives = 202/235 (86%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHCILYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLLVRIGKHSRTRYERNVEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I VHP+YNW+ENL+RDIALL +++P+ F+D IHPVCLP KQ   +L+ AGYKGRVTGWGN
Sbjct  84   IYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVCLPDKQTVTSLLRAGYKGRVTGWGN  143

Query  121  LYETWSSSPKSL-PTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++   + P+VLQ ++LPIVE+ +C+ ST IRITDNMFCAGFK  + K GDACEG
Sbjct  144  LRETWTTNINEIQPSVLQVVNLPIVERPVCKASTRIRITDNMFCAGFKVNDTKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDR GKYGFYTH+FR++ W++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKAWIQKVIDQFG  258


>5EDM_A Chain A, Crystal Structure Of Prothrombin Deletion Mutant Residues 
154-167 (Form I)
Length=568

 Score = 372 bits (956),  Expect = 1e-127, Method: Compositional matrix adjust.
 Identities = 162/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  330  QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  389

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  390  IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  449

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  450  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  509

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  510  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  564


>5EDK_A Chain A, Crystal Structure Of Prothrombin Deletion Mutant Residues 
146-167 (Form Ii).
Length=560

 Score = 372 bits (956),  Expect = 1e-127, Method: Compositional matrix adjust.
 Identities = 162/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  322  QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  381

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  382  IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  441

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  442  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  501

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  502  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  556


>4NZQ_A Chain A, Crystal Structure Of Ca2+-free Prothrombin Deletion 
Mutant Residues 146-167
 4O03_A Chain A, Crystal Structure Of Ca2+ Bound Prothrombin Deletion 
Mutant Residues 146-167
Length=557

 Score = 372 bits (955),  Expect = 2e-127, Method: Compositional matrix adjust.
 Identities = 162/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  322  QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  381

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  382  IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  441

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  442  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  501

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  502  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  556


>1VR1_H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length=261

 Score = 361 bits (927),  Expect = 2e-127, Method: Compositional matrix adjust.
 Identities = 157/233 (67%), Positives = 204/233 (88%), Gaps = 1/233 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            +  LCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  28   ERFLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  87

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  88   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  147

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCA +KP+E K GDACEG
Sbjct  148  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAYYKPDEGKRGDACEG  207

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDK  232
            DSGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+
Sbjct  208  DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQ  260


>4HZH_A Chain A, Structure Of Recombinant Gla-domainless Prothrombin 
Mutant S525a
 4HZH_B Chain B, Structure Of Recombinant Gla-domainless Prothrombin 
Mutant S525a
Length=533

 Score = 371 bits (952),  Expect = 2e-127, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 208/235 (89%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  298  QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  357

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  358  IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  417

Query  121  LYETWSSS-PKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++  K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEG
Sbjct  418  LKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEG  477

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            D+GGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  478  DAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  532


>3GIC_B Chain B, Structure Of Thrombin Mutant Delta(146-149e) In The 
Free Form
Length=250

 Score = 361 bits (926),  Expect = 2e-127, Method: Compositional matrix adjust.
 Identities = 159/234 (68%), Positives = 202/234 (86%), Gaps = 8/234 (3%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGD  180
            L        K  P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEGD
Sbjct  144  L--------KGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGD  195

Query  181  SGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            SGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  196  SGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  249


>1VZQ_H Chain H, Complex Of Thrombin With Designed Inhibitor 7165
Length=250

 Score = 360 bits (925),  Expect = 3e-127, Method: Compositional matrix adjust.
 Identities = 159/232 (69%), Positives = 201/232 (87%), Gaps = 6/232 (3%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R  +E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTAYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGD  180
            L ET        P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEGD
Sbjct  144  LKET------GQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGD  197

Query  181  SGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDK  232
            SGGPFVMKSP +NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+
Sbjct  198  SGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQ  249


>3EDX_B Chain B, Crystal Structure Of The W215aE217A MUTANT OF MURINE 
THROMBIN
 3EDX_D Chain D, Crystal Structure Of The W215aE217A MUTANT OF MURINE 
THROMBIN
 3EDX_F Chain F, Crystal Structure Of The W215aE217A MUTANT OF MURINE 
THROMBIN
 3HK3_B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A 
(ONE Molecule In The Asymmetric Unit)
 3HK6_B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A 
(TWO Molecules In The Asymmetric Unit)
 3HK6_D Chain D, Crystal Structure Of Murine Thrombin Mutant W215aE217A 
(TWO Molecules In The Asymmetric Unit)
 3HKI_B Chain B, Crystal Structure Of Murine Thrombin Mutant W215a/e217a 
In Complex With The Extracellular Fragment Of Human Par1
 3HKI_E Chain E, Crystal Structure Of Murine Thrombin Mutant W215a/e217a 
In Complex With The Extracellular Fragment Of Human Par1
Length=258

 Score = 358 bits (920),  Expect = 2e-126, Method: Compositional matrix adjust.
 Identities = 161/235 (69%), Positives = 201/235 (86%), Gaps = 1/235 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHCILYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLLVRIGKHSRTRYERNVEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I VHP+YNW+ENL+RDIALL +++P+ F+D IHPVCLP KQ   +L+ AGYKGRVTGWGN
Sbjct  84   IYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVCLPDKQTVTSLLRAGYKGRVTGWGN  143

Query  121  LYETWSSSPKSL-PTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
            L ETW+++   + P+VLQ ++LPIVE+ +C+ ST IRITDNMFCAGFK  + K GDACEG
Sbjct  144  LRETWTTNINEIQPSVLQVVNLPIVERPVCKASTRIRITDNMFCAGFKVNDTKRGDACEG  203

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            DSGGPFVMKSP +NRWYQ+GIVS G GCDR GKYGFYTH+FR++RW++KVID+ G
Sbjct  204  DSGGPFVMKSPFNNRWYQMGIVSAGAGCDRKGKYGFYTHVFRLKRWIQKVIDQFG  258


>1BBR_H Chain H, The Structure Of Residues 7-16 Of The A Alpha Chain 
Of Human Fibrinogen Bound To Bovine Thrombin At 2.3 Angstroms 
Resolution
 1UCY_H Chain H, Thrombin Complexed With Fibrinopeptide A Alpha (Residues 
7- 19). Three Complexes, One With Epsilon-Thrombin And 
Two With Alpha-Thrombin
 1VIT_F Chain F, Thrombin:hirudin 51-65 Complex
 1YCP_K Chain K, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 
(F8y) Bound To Bovine Thrombin Explains Why The Mutation Of 
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At Arginine-16
Length=150

 Score = 200 bits (509),  Expect = 2e-65, Method: Compositional matrix adjust.
 Identities = 86/127 (68%), Positives = 109/127 (86%), Gaps = 0/127 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT++D+LVR+GKH+R ++E+  EKI  +D+
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLLVRIGKHSRTRYERKVEKISMLDK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNWKENL+RDIALL ++RPI  +D IHPVCLP KQ A  L+ AG+KGRVTGWGN
Sbjct  84   IYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWGN  143

Query  121  LYETWSS  127
              ETW++
Sbjct  144  RRETWTT  150


>1BHX_B Chain B, X-Ray Structure Of The Complex Of Human Alpha Thrombin 
With The Inhibitor Sdz 229-357
 1RIW_B Chain B, Thrombin In Complex With Natural Product Inhibitor Oscillarin
 2PKS_B Chain B, Thrombin In Complex With Inhibitor
 3PO1_B Chain B, Thrombin In Complex With Benzothiazole Guanidine
Length=147

 Score = 195 bits (495),  Expect = 2e-63, Method: Compositional matrix adjust.
 Identities = 82/124 (66%), Positives = 108/124 (87%), Gaps = 0/124 (0%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            QELLCGASLISD W+LTAAHC+LYPPW+KNFT ND+LVR+GKH+R ++E+  EKI  +++
Sbjct  24   QELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEK  83

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I +HP+YNW+ENL+RDIAL+ +++P+ F+D IHPVCLP ++ A +L+ AGYKGRVTGWGN
Sbjct  84   IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN  143

Query  121  LYET  124
            L ET
Sbjct  144  LKET  147


>2HNT_F Chain F, Crystallographic Structure Of Human Gamma-Thrombin
 1BHX_F Chain F, X-Ray Structure Of The Complex Of Human Alpha Thrombin 
With The Inhibitor Sdz 229-357
 1RIW_C Chain C, Thrombin In Complex With Natural Product Inhibitor Oscillarin
Length=105

 Score = 178 bits (451),  Expect = 2e-57, Method: Compositional matrix adjust.
 Identities = 78/102 (76%), Positives = 95/102 (93%), Gaps = 0/102 (0%)

Query  133  PTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDSGGPFVMKSPDD  192
            P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEGDSGGPFVMKSP +
Sbjct  3    PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN  62

Query  193  NRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  63   NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG  104


>2PKS_C Chain C, Thrombin In Complex With Inhibitor
 3PO1_C Chain C, Thrombin In Complex With Benzothiazole Guanidine
Length=102

 Score = 176 bits (447),  Expect = 7e-57, Method: Compositional matrix adjust.
 Identities = 77/100 (77%), Positives = 94/100 (94%), Gaps = 0/100 (0%)

Query  133  PTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDSGGPFVMKSPDD  192
            P+VLQ ++LPIVE+ +C+DST IRITDNMFCAG+KP+E K GDACEGDSGGPFVMKSP +
Sbjct  3    PSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN  62

Query  193  NRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDK  232
            NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+
Sbjct  63   NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQ  102


>1BBR_E Chain E, The Structure Of Residues 7-16 Of The A Alpha Chain 
Of Human Fibrinogen Bound To Bovine Thrombin At 2.3 Angstroms 
Resolution
 1UCY_E Chain E, Thrombin Complexed With Fibrinopeptide A Alpha (Residues 
7- 19). Three Complexes, One With Epsilon-Thrombin And 
Two With Alpha-Thrombin
 1VIT_G Chain G, Thrombin:hirudin 51-65 Complex
 1YCP_M Chain M, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 
(F8y) Bound To Bovine Thrombin Explains Why The Mutation Of 
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At Arginine-16
Length=109

 Score = 176 bits (446),  Expect = 1e-56, Method: Compositional matrix adjust.
 Identities = 76/102 (75%), Positives = 93/102 (91%), Gaps = 0/102 (0%)

Query  133  PTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDSGGPFVMKSPDD  192
            P+VLQ ++LP+VE+ +C+ ST IRITDNMFCAG+KP E K GDACEGDSGGPFVMKSP +
Sbjct  7    PSVLQVVNLPLVERPVCKASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYN  66

Query  193  NRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            NRWYQ+GIVSWGEGCDRDGKYGFYTH+FR+++W++KVID+ G
Sbjct  67   NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDRLG  108


>1FAX_A Chain A, Coagulation Factor Xa Inhibitor Complex
Length=254

 Score = 157 bits (398),  Expect = 2e-47, Method: Compositional matrix adjust.
 Identities = 86/233 (37%), Positives = 134/233 (58%), Gaps = 20/233 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            E  CG +++S+ +ILTAAHC+        +      VR+G  N A  E+G E +  ++ +
Sbjct  24   EGFCGGTILSEFYILTAAHCL--------YQAKRFKVRVGDRNTAA-EEGGEAVHEVEVV  74

Query  62   IVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNL  121
            I H ++  KE  + DIA+L ++ PITF   + P CLP +  A++ +     G V+G+G  
Sbjct  75   IKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT  133

Query  122  YETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDS  181
            +E    S     T L+ + +P V+++ C+ S+S  IT NMFCAG+  +++   DAC+GDS
Sbjct  134  HEKGRQS-----TRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQE---DACQGDS  185

Query  182  GGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            GGP V +  D   ++  GIVSWGEGC R GKYG YT +    +W+ + +   G
Sbjct  186  GGPHVTRFKDT--YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRG  236


>2BOK_A Chain A, Factor Xa- Cation
 2JKH_A Chain A, Factor Xa - Cation Inhibitor Complex
 2VVC_A Chain A, Aminopyrrolidine Factor Xa Inhibitor
 2VVC_B Chain B, Aminopyrrolidine Factor Xa Inhibitor
 2VVU_A Chain A, Aminopyrrolidine Factor Xa Inhibitor
 2VVV_A Chain A, Aminopyrrolidine-Related Triazole Factor Xa Inhibitor
 2VWL_A Chain A, Aminopyrrolidine Factor Xa Inhibitor
 2VWM_A Chain A, Aminopyrrolidine Factor Xa Inhibitor
 2VWM_B Chain B, Aminopyrrolidine Factor Xa Inhibitor
 2VWN_A Chain A, Aminopyrrolidine Factor Xa Inhibitor
 2VWO_A Chain A, Aminopyrrolidine Factor Xa Inhibitor
 2XBV_A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic 
Acid Inhibitor
Length=241

 Score = 156 bits (394),  Expect = 5e-47, Method: Compositional matrix adjust.
 Identities = 85/233 (36%), Positives = 134/233 (58%), Gaps = 20/233 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            E  CG +++S+ +ILTAAHC+        +      VR+G  N  + E+G E +  ++ +
Sbjct  24   EGFCGGTILSEFYILTAAHCL--------YQAKRFKVRVGDRNTEQ-EEGGEAVHEVEVV  74

Query  62   IVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNL  121
            I H ++  KE  + DIA+L ++ PITF   + P CLP +  A++ +     G V+G+G  
Sbjct  75   IKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT  133

Query  122  YETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDS  181
            +E    S     T L+ + +P V+++ C+ S+S  IT NMFCAG+  +++   DAC+GDS
Sbjct  134  HEKGEQS-----TRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQE---DACQGDS  185

Query  182  GGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            GGP V +  D   ++  GIVSWGEGC R GKYG YT +    +W+ + +   G
Sbjct  186  GGPHVTRFKDT--YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRG  236


>3ENS_B Chain B, Crystal Structure Of Human Fxa In Complex With Methyl 
(2z)-3-[(3- Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-oxo-2- 
Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
 3ENS_D Chain D, Crystal Structure Of Human Fxa In Complex With Methyl 
(2z)-3-[(3- Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-oxo-2- 
Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
 3HPT_B Chain B, Crystal Structure Of Human Fxa In Complex With (S)-2-Cyano-1-(2- 
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-1-Yl)ethyl) 
Azepan-3-Yl)guanidine
 3HPT_D Chain D, Crystal Structure Of Human Fxa In Complex With (S)-2-Cyano-1-(2- 
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-1-Yl)ethyl) 
Azepan-3-Yl)guanidine
 3K9X_B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With 
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2- (Pyrrolidin-1-Yl) 
Ethyl)azepan-3- Ylamino)methylene)nicotinamide
 3K9X_D Chain D, X-Ray Crystal Structure Of Human Fxa In Complex With 
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2- (Pyrrolidin-1-Yl) 
Ethyl)azepan-3- Ylamino)methylene)nicotinamide
 3SW2_B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With 
6-Chloro-N-((3s)- 2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,5-Methanopyrido[1,2- 
A][1,5]diazocin-3(2h,4h,8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- 
Sulfonamide
Length=238

 Score = 156 bits (394),  Expect = 6e-47, Method: Compositional matrix adjust.
 Identities = 85/233 (36%), Positives = 134/233 (58%), Gaps = 20/233 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            E  CG +++S+ +ILTAAHC+        +      VR+G  N  + E+G E +  ++ +
Sbjct  24   EGFCGGTILSEFYILTAAHCL--------YQAKRFKVRVGDRNTEQ-EEGGEAVHEVEVV  74

Query  62   IVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNL  121
            I H ++  KE  + DIA+L ++ PITF   + P CLP +  A++ +     G V+G+G  
Sbjct  75   IKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT  133

Query  122  YETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDS  181
            +E    S     T L+ + +P V+++ C+ S+S  IT NMFCAG+  +++   DAC+GDS
Sbjct  134  HEKGRQS-----TRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQE---DACQGDS  185

Query  182  GGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            GGP V +  D   ++  GIVSWGEGC R GKYG YT +    +W+ + +   G
Sbjct  186  GGPHVTRFKDT--YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRG  236


>1HCG_A Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms 
Resolution
 3KL6_A Chain A, Discovery Of Tetrahydropyrimidin-2(1h)-one Derivative 
Tak-442: A Potent, Selective And Orally Active Factor Xa Inhibitor
 2XBW_A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic 
Acid Inhibitor
 2XBX_A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic 
Acid Inhibitor
 2XBY_A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic 
Acid Inhibitor
 2XC0_A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic 
Acid Inhibitor
 2XC4_A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic 
Acid Inhibitor
 2XC5_A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic 
Acid Inhibitor
Length=241

 Score = 156 bits (394),  Expect = 6e-47, Method: Compositional matrix adjust.
 Identities = 85/233 (36%), Positives = 134/233 (58%), Gaps = 20/233 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            E  CG +++S+ +ILTAAHC+        +      VR+G  N  + E+G E +  ++ +
Sbjct  24   EGFCGGTILSEFYILTAAHCL--------YQAKRFKVRVGDRNTEQ-EEGGEAVHEVEVV  74

Query  62   IVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNL  121
            I H ++  KE  + DIA+L ++ PITF   + P CLP +  A++ +     G V+G+G  
Sbjct  75   IKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT  133

Query  122  YETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDS  181
            +E    S     T L+ + +P V+++ C+ S+S  IT NMFCAG+  +++   DAC+GDS
Sbjct  134  HEKGRQS-----TRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQE---DACQGDS  185

Query  182  GGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            GGP V +  D   ++  GIVSWGEGC R GKYG YT +    +W+ + +   G
Sbjct  186  GGPHVTRFKDT--YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRG  236


>1C5M_D Chain D, Structural Basis For Selectivity Of A Small Molecule, 
S1- Binding, Sub-Micromolar Inhibitor Of Urokinase Type Plasminogen 
Activator
Length=255

 Score = 156 bits (394),  Expect = 8e-47, Method: Compositional matrix adjust.
 Identities = 85/233 (36%), Positives = 134/233 (58%), Gaps = 20/233 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            E  CG +++S+ +ILTAAHC+        +      VR+G  N  + E+G E +  ++ +
Sbjct  24   EGFCGGTILSEFYILTAAHCL--------YQAKRFKVRVGDRNTEQ-EEGGEAVHEVEVV  74

Query  62   IVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNL  121
            I H ++  KE  + DIA+L ++ PITF   + P CLP +  A++ +     G V+G+G  
Sbjct  75   IKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT  133

Query  122  YETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDS  181
            +E    S     T L+ + +P V+++ C+ S+S  IT NMFCAG+  +++   DAC+GDS
Sbjct  134  HEKGRQS-----TRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQE---DACQGDS  185

Query  182  GGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            GGP V +  D   ++  GIVSWGEGC R GKYG YT +    +W+ + +   G
Sbjct  186  GGPHVTRFKDT--YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRG  236


>1EZQ_A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed 
With Rpr128515
 1F0R_A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed 
With Rpr208815
 1F0S_A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed 
With Rpr208707
 1KSN_A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed 
With Fxv673
 1NFU_A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed 
With Rpr132747
 1NFW_A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed 
With Rpr209685
 1NFX_A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed 
With Rpr208944
 1NFY_A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed 
With Rpr200095
 1LPG_B Chain B, Crystal Structure Of Fxa In Complex With 79.
 1LPK_B Chain B, Crystal Structure Of Fxa In Complex With 125.
 1LPZ_B Chain B, Crystal Structure Of Fxa In Complex With 41.
 1LQD_B Chain B, Crystal Structure Of Fxa In Complex With 45.
 1P0S_H Chain H, Crystal Structure Of Blood Coagulation Factor Xa In 
Complex With Ecotin M84r
 2BOH_B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 
"1"
 2CJI_A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
 2J2U_A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
 2J34_A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
 2J38_A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
 2J4I_A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
 2J94_A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
 2J95_A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
 2UWL_A Chain A, Selective And Dual Action Orally Active Inhibitors Of 
Thrombin And Factor Xa
 2UWO_A Chain A, Selective And Dual Action Orally Active Inhibitors Of 
Thrombin And Factor Xa
 2UWP_A Chain A, Factor Xa Inhibitor Complex
 2VH0_A Chain A, Structure And Property Based Design Of Factor Xa Inhibitors: 
Biaryl Pyrrolidin-2-Ones Incorporating Basic Heterocyclic 
Motifs
 2VH6_A Chain A, Structure And Property Based Design Of Factor Xa Inhibitors: 
Pyrrolidin-2-Ones With Biaryl P4 Motifs
 2WYG_A Chain A, Structure And Property Based Design Of Factor Xa Inhibitors: 
Pyrrolidin-2-Ones With Monoaryl P4 Motifs
 2WYJ_A Chain A, Structure And Property Based Design Of Factor Xa Inhibitors: 
Pyrrolidin-2-Ones With Monoaryl P4 Motifs
 2Y7X_A Chain A, The Discovery Of Potent And Long-Acting Oral Factor 
Xa Inhibitors With Tetrahydroisoquinoline And Benzazepine P4 
Motifs
 2Y7Z_A Chain A, Structure And Property Based Design Of Factor Xa Inhibitors: 
Pyrrolidin-2-Ones With Aminoindane And Phenylpyrrolidine 
P4 Motifs
 2Y80_A Chain A, Structure And Property Based Design Of Factor Xa Inhibitors: 
Pyrrolidin-2-Ones With Aminoindane And Phenylpyrrolidine 
P4 Motifs
 2Y81_A Chain A, Structure And Property Based Design Of Factor Xa Inhibitors: 
Pyrrolidin-2-Ones With Aminoindane And Phenylpyrrolidine 
P4 Motifs
 2Y82_A Chain A, Structure And Property Based Design Of Factor Xa Inhibitors: 
Pyrrolidin-2-Ones With Aminoindane And Phenylpyrrolidine 
P4 Motifs
 4A7I_B Chain B, Factor Xa In Complex With A Potent 2-Amino-Ethane Sulfonamide 
Inhibitor
 4BTT_B Chain B, Factor Xa In Complex With The Dual Thrombin-fxa Inhibitor 
31.
 4BTT_F Chain F, Factor Xa In Complex With The Dual Thrombin-fxa Inhibitor 
31.
 4BTU_B Chain B, Factor Xa In Complex With The Dual Thrombin-fxa Inhibitor 
57.
 4BTU_F Chain F, Factor Xa In Complex With The Dual Thrombin-fxa Inhibitor 
57.
 4BTI_B Chain B, Factor Xa In Complex With The Dual Thrombin-fxa Inhibitor 
58.
 4BTI_F Chain F, Factor Xa In Complex With The Dual Thrombin-fxa Inhibitor 
58.
 4Y6D_A Chain A, Factor Xa Complex With Gtc000101
 4Y71_A Chain A, Factor Xa Complex With Gtc000398
 4Y76_A Chain A, Factor Xa Complex With Gtc000401
 4Y79_A Chain A, Factor Xa Complex With Gtc000406
 4Y7A_A Chain A, Factor Xa Complex With Gtc000422
 4Y7B_A Chain A, Factor Xa Complex With Gtc000441
 4ZH8_A Chain A, Factor Xa Complex With Gtc000006
 4ZHA_A Chain A, Factor Xa Complex With Gtc000102
Length=254

 Score = 156 bits (394),  Expect = 8e-47, Method: Compositional matrix adjust.
 Identities = 85/233 (36%), Positives = 134/233 (58%), Gaps = 20/233 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            E  CG +++S+ +ILTAAHC+        +      VR+G  N  + E+G E +  ++ +
Sbjct  24   EGFCGGTILSEFYILTAAHCL--------YQAKRFKVRVGDRNTEQ-EEGGEAVHEVEVV  74

Query  62   IVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNL  121
            I H ++  KE  + DIA+L ++ PITF   + P CLP +  A++ +     G V+G+G  
Sbjct  75   IKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT  133

Query  122  YETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDS  181
            +E    S     T L+ + +P V+++ C+ S+S  IT NMFCAG+  +++   DAC+GDS
Sbjct  134  HEKGRQS-----TRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQE---DACQGDS  185

Query  182  GGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            GGP V +  D   ++  GIVSWGEGC R GKYG YT +    +W+ + +   G
Sbjct  186  GGPHVTRFKDT--YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRG  236


>2Y5F_A Chain A, Factor Xa - Cation Inhibitor Complex
 2Y5G_A Chain A, Factor Xa - Cation Inhibitor Complex
 2Y5H_A Chain A, Factor Xa - Cation Inhibitor Complex
Length=234

 Score = 155 bits (391),  Expect = 1e-46, Method: Compositional matrix adjust.
 Identities = 84/229 (37%), Positives = 133/229 (58%), Gaps = 20/229 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            E  CG +++S+ +ILTAAHC+        +      VR+G  N  + E+G E +  ++ +
Sbjct  24   EGFCGGTILSEFYILTAAHCL--------YQAKRFKVRVGDRNTEQ-EEGGEAVHEVEVV  74

Query  62   IVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNL  121
            I H ++  KE  + DIA+L ++ PITF   + P CLP +  A++ +     G V+G+G  
Sbjct  75   IKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT  133

Query  122  YETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDS  181
            +E    S     T L+ + +P V+++ C+ S+S  IT NMFCAG+  +++   DAC+GDS
Sbjct  134  HEKGEQS-----TRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQE---DACQGDS  185

Query  182  GGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVI  230
            GGP V +  D   ++  GIVSWGEGC R GKYG YT +    +W+ + +
Sbjct  186  GGPHVTRFKDT--YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM  232


>1XKA_C Chain C, Factor Xa Complexed With A Synthetic Inhibitor Fx-2212a,(2s)-(3'- 
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic 
Acid
 1XKB_C Chain C, Factor Xa Complexed With A Synthetic Inhibitor Fx-2212a,(2s)-(3'- 
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic 
Acid
 1XKB_D Chain D, Factor Xa Complexed With A Synthetic Inhibitor Fx-2212a,(2s)-(3'- 
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic 
Acid
 1G2L_A Chain A, Factor Xa Inhibitor Complex
 1G2M_A Chain A, Factor Xa Inhibitor Complex
 1IOE_A Chain A, Human Coagulation Factor Xa In Complex With M55532
 1IQE_A Chain A, Human Coagulation Factor Xa In Complex With M55590
 1IQF_A Chain A, Human Coagulation Factor Xa In Complex With M55165
 1IQG_A Chain A, Human Coagulation Factor Xa In Complex With M55159
 1IQH_A Chain A, Human Coagulation Factor Xa In Complex With M55143
 1IQI_A Chain A, Human Coagulation Factor Xa In Complex With M55125
 1IQJ_A Chain A, Human Coagulation Factor Xa In Complex With M55124
 1IQK_A Chain A, Human Coagulation Factor Xa In Complex With M55113
 1IQL_A Chain A, Human Coagulation Factor Xa In Complex With M54476
 1IQM_A Chain A, Human Coagulation Factor Xa In Complex With M54471
 1IQN_A Chain A, Human Coagulation Factor Xa In Complex With M55192
 2P3F_H Chain H, Crystal Structure Of The Factor XaNAP5 COMPLEX
Length=235

 Score = 155 bits (391),  Expect = 1e-46, Method: Compositional matrix adjust.
 Identities = 84/229 (37%), Positives = 133/229 (58%), Gaps = 20/229 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            E  CG +++S+ +ILTAAHC+        +      VR+G  N  + E+G E +  ++ +
Sbjct  24   EGFCGGTILSEFYILTAAHCL--------YQAKRFKVRVGDRNTEQ-EEGGEAVHEVEVV  74

Query  62   IVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNL  121
            I H ++  KE  + DIA+L ++ PITF   + P CLP +  A++ +     G V+G+G  
Sbjct  75   IKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT  133

Query  122  YETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDS  181
            +E    S     T L+ + +P V+++ C+ S+S  IT NMFCAG+  +++   DAC+GDS
Sbjct  134  HEKGRQS-----TRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQE---DACQGDS  185

Query  182  GGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVI  230
            GGP V +  D   ++  GIVSWGEGC R GKYG YT +    +W+ + +
Sbjct  186  GGPHVTRFKDT--YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM  232


>1FJS_A Chain A, Crystal Structure Of The Inhibitor Zk-807834 (Ci-1031) 
Complexed With Factor Xa
 1Z6E_A Chain A, Factor Xa In Complex With The Inhibitor 1-(3'-Amino-1,2-Benzisoxazol- 
5'-Yl)-N-(4-(2'-((Dimethylamino)methyl)-1h-Imidazol-1-Yl)-2- 
Fluorophenyl)-3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide 
(Razaxaban; Dpc906; Bms-561389)
 2BMG_B Chain B, Crystal Structure Of Factor Xa In Complex With 50
 2FZZ_A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-Amino-1,2- 
Benzisoxazol-5-Yl)-6-(2'-(((3r)-3-Hydroxy-1-Pyrrolidinyl) 
Methyl)-4-Biphenylyl)-3-(Trifluoromethyl)-1,4,5,6- Tetrahydro-7h-Pyrazolo[3,4-C]pyridin-7-One
 2G00_A Chain A, Factor Xa In Complex With The Inhibitor 3-(6-(2'- ((Dimethylamino)methyl)-4-Biphenylyl)-7-Oxo-3- 
(Trifluoromethyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3,4- 
C]pyridin-1-Yl)benzamide
 2P93_A Chain A, Factor Xa In Complex With The Inhibitor 5-Chloro-N-(2-(4-(2- 
Oxopyridin-1(2h)-Yl)benzamido)ethyl)thiophene-2-Carboxamide
 2P94_A Chain A, Factor Xa In Complex With The Inhibitor 3-Chloro-N-((1r,2s)- 
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido)cyclohexyl)-1h- 
Indole-6-Carboxamide
 2P95_A Chain A, Factor Xa In Complex With The Inhibitor 5-Chloro-N-((1r,2s)- 
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido) Cyclopentyl) 
Thiophene-2-Carboxamide
 2PR3_A Chain A, Factor Xa Inhibitor
 2Q1J_A Chain A, The Discovery Of Glycine And Related Amino Acid-Based 
Factor Xa Inhibitors
 2P16_A Chain A, Factor Xa In Complex With The Inhibitor Apixaban (Bms- 
562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1- Piperidinyl)phenyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3, 
4- C]pyridine-3-Carboxamide
 2RA0_A Chain A, X-Ray Structure Of Fxa In Complex With 7-Fluoroindazole
 2PHB_A Chain A, An Orally Efficacious Factor Xa Inhibitor
 3CEN_A Chain A, Factor Xa In Complex With The Inhibitor N-(2-(((5-Chloro-2- 
Pyridinyl) Amino)sulfonyl)phenyl)-4-(2-Oxo-1(2h)- Pyridinyl)benzamide
 3CS7_A Chain A, Factor Xa In Complex With The Inhibitor 1-(4-Methoxyphenyl)- 
6-(4-(1-(Pyrrolidin-1-Ylmethyl)cyclopropyl)phenyl)-3- 
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin- 
7(4h)-One
 2W26_A Chain A, Factor Xa In Complex With Bay59-7939
 2W3I_A Chain A, Crystal Structure Of Fxa In Complex With 4,4-disubstituted 
Pyrrolidine-1,2-dicarboxamide Inhibitor 2
 2W3K_A Chain A, Crystal Structure Of Fxa In Complex With 4,4-Disubstituted 
Pyrrolidine-1,2-Dicarboxamide Inhibitor 1
 3FFG_A Chain A, Factor Xa In Complex With The Inhibitor (R)-6-(2'-((3- 
Hydroxypyrrolidin-1-Yl)methyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4, 
5-Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-3- (Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin- 
7(4h)-One
 3KQB_A Chain A, Factor Xa In Complex With The Inhibitor N-(3-Fluoro-2'- 
(Methylsulfonyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h- 
Triazol-3-Yl)phenyl)-3-(Trifluoromethyl)-1h- Pyrazole-5-Car
 3KQC_A Chain A, Factor Xa In Complex With The Inhibitor 6-(2'- (Methylsulfon 
Biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h- 1,2,4-Triazol-3- 
Phenyl)-3-(Trifluoromethyl)-5,6- Dihydro-1h-Pyrazolo[3,4-C] 
7(4h)-One
 3KQD_A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-(5-Oxo-4,5- 
Dih 2,4-Triazol-3-Yl)phenyl)-6-(2'-(Pyrrolidin-1- Ylmethyl)biph 
Yl)-3-(Trifluoromethyl)-5,6-Dihydro- 1h-Pyrazolo[3,4-C]pyri 
One
 3KQE_A Chain A, Factor Xa In Complex With The Inhibitor 3-Methyl-1-(3-(5- 
Ox Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-6-(2'- (Pyrrolidin-1- 
Biphenyl-4-Yl)-5,6-Dihydro-1h- Pyrazolo[3,4-C]pyridin-7(4h)
 3LIW_A Chain A, Factor Xa In Complex With (R)-2-(1-Adamantylcarbamoylamino)- 
3-(3-Carbamidoyl-Phenyl)-N-Phenethyl-Propionic Acid 
Amide
 3M36_A Chain A, Factor Xa In Complex With The Inhibitor 1-[3-(Aminomethyl) 
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3- 
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
 3M37_A Chain A, Factor Xa In Complex With The Inhibitor 1-[2-(Aminomethyl) 
Phenyl]-N-(3-Fluoro-2'-Sulfamoylbiphenyl-4-Yl)-3- (Trifluoromethyl)-1h-Pyrazole-5-Carboxamide 
(Dpc602)
 5K0H_A Chain A, Human Factor Xa In Complex With Synthetic Inhibitor 
Benzylsulfonyl- Dser(benzyl)-gly-4-amidinobenzylamide
Length=234

 Score = 155 bits (391),  Expect = 1e-46, Method: Compositional matrix adjust.
 Identities = 84/229 (37%), Positives = 133/229 (58%), Gaps = 20/229 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            E  CG +++S+ +ILTAAHC+        +      VR+G  N  + E+G E +  ++ +
Sbjct  24   EGFCGGTILSEFYILTAAHCL--------YQAKRFKVRVGDRNTEQ-EEGGEAVHEVEVV  74

Query  62   IVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNL  121
            I H ++  KE  + DIA+L ++ PITF   + P CLP +  A++ +     G V+G+G  
Sbjct  75   IKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT  133

Query  122  YETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDS  181
            +E    S     T L+ + +P V+++ C+ S+S  IT NMFCAG+  +++   DAC+GDS
Sbjct  134  HEKGRQS-----TRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQE---DACQGDS  185

Query  182  GGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVI  230
            GGP V +  D   ++  GIVSWGEGC R GKYG YT +    +W+ + +
Sbjct  186  GGPHVTRFKDT--YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM  232


>2GD4_H Chain H, Crystal Structure Of The Antithrombin-S195a Factor Xa-Pentasaccharide 
Complex
 2GD4_B Chain B, Crystal Structure Of The Antithrombin-S195a Factor Xa-Pentasaccharide 
Complex
Length=241

 Score = 155 bits (391),  Expect = 2e-46, Method: Compositional matrix adjust.
 Identities = 84/233 (36%), Positives = 134/233 (58%), Gaps = 20/233 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            E  CG +++S+ +ILTAAHC+        +      VR+G  N  + E+G E +  ++ +
Sbjct  24   EGFCGGTILSEFYILTAAHCL--------YQAKRFKVRVGDRNTEQ-EEGGEAVHEVEVV  74

Query  62   IVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNL  121
            I H ++  KE  + DIA+L ++ PITF   + P CLP +  A++ +     G V+G+G  
Sbjct  75   IKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT  133

Query  122  YETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDS  181
            +E    S     T L+ + +P V+++ C+ S+S  IT NMFCAG+  +++   DAC+GD+
Sbjct  134  HEKGRQS-----TRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQE---DACQGDA  185

Query  182  GGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTG  234
            GGP V +  D   ++  GIVSWGEGC R GKYG YT +    +W+ + +   G
Sbjct  186  GGPHVTRFKDT--YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRG  236


>1MQ5_A Chain A, Crystal Structure Of 3-chloro-n-[4-chloro-2-[[(4-chlorophenyl) 
Amino]carbonyl]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]-2- 
Thiophenecarboxamide Complexed With Human Factor 
Xa
 1MQ6_A Chain A, Crystal Structure Of 3-Chloro-N-[4-Chloro-2-[[(5-Chloro-2-Pyridinyl) 
Amino]carbonyl]-6-Methoxyphenyl]-4-[[(4,5-Dihydro-2-Oxazolyl) 
Methylamino]methyl]-2-Thiophenecarboxamide 
Complexed With Human Factor Xa
 1V3X_A Chain A, Factor Xa In Complex With The Inhibitor 1-[6-Methyl-4,5,6,7- 
Tetrahydrothiazolo(5,4-C)pyridin-2-Yl] Carbonyl-2- 
Carbamoyl-4-(6-Chloronaphth-2-Ylsulphonyl)piperazine
 1WU1_A Chain A, Factor Xa In Complex With The Inhibitor 4-[(5-Chloroindol-2-Yl) 
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl) 
Pyrimidin-2- Yl]carbonyl]piperazine
 2D1J_A Chain A, Factor Xa In Complex With The Inhibitor 2-[[4-[(5- Chloroindol-2-Yl)sulfonyl]piperazin-1-Yl] 
Carbonyl]thieno[3,2-B]pyridine 
N-Oxide
 2H9E_H Chain H, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
 2P3U_B Chain B, Crystal Structure Of Human Factor Xa Complexed With 
3- Chloro-N-(4-Chloro-2-{[(5-Chloropyridin-2-Yl) Amino]carbonyl}-6-Methoxyphenyl)-4-[(1-Methyl-1h-Imidazol- 
2-Yl)methyl]thiophene-2-Carboxamide 
{pfizer 320663}
 2P3T_B Chain B, Crystal Structure Of Human Factor Xa Complexed With 
3- Chloro-4-(2-Methylamino-Imidazol-1-Ylmethyl)-Thiophene-2- 
Carboxylic Acid [4-Chloro-2-(5-Chloro-Pyridin-2- Ylcarbamoyl)-6-Methoxy-Phenyl]-Amide
 2EI6_A Chain A, Factor Xa In Complex With The Inhibitor (-)-Cis-N1-[(5- 
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7- Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2- 
Cyclohexanediamine
 2EI7_A Chain A, Factor Xa In Complex With The Inhibitor Trans-N1-[(5- 
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7- Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2- 
Cyclohexanediamine
 2EI8_A Chain A, Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5- 
Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2- 
[(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,4-C]pyridin-2-Yl) 
Carbonyl]-1,2-Cyclohexanediamine
 3IIT_A Chain A, Factor Xa In Complex With A Cis-1,2-Diaminocyclohexane 
Derivative
 3Q3K_A Chain A, Factor Xa In Complex With A Phenylenediamine Derivative
 3TK5_A Chain A, Factor Xa In Complex With D102-4380
 3TK6_A Chain A, Factor Xa In Complex With D46-5241
Length=233

 Score = 154 bits (390),  Expect = 2e-46, Method: Compositional matrix adjust.
 Identities = 84/229 (37%), Positives = 133/229 (58%), Gaps = 20/229 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            E  CG +++S+ +ILTAAHC+        +      VR+G  N  + E+G E +  ++ +
Sbjct  24   EGFCGGTILSEFYILTAAHCL--------YQAKRFKVRVGDRNTEQ-EEGGEAVHEVEVV  74

Query  62   IVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNL  121
            I H ++  KE  + DIA+L ++ PITF   + P CLP +  A++ +     G V+G+G  
Sbjct  75   IKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT  133

Query  122  YETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDS  181
            +E    S     T L+ + +P V+++ C+ S+S  IT NMFCAG+  +++   DAC+GDS
Sbjct  134  HEKGRQS-----TRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQE---DACQGDS  185

Query  182  GGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVI  230
            GGP V +  D   ++  GIVSWGEGC R GKYG YT +    +W+ + +
Sbjct  186  GGPHVTRFKDT--YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM  232


>2BQ6_B Chain B, Crystal Structure Of Factor Xa In Complex With 21
 2BQ7_B Chain B, Crystal Structure Of Factor Xa In Complex With 43
 2BQW_B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 
45
Length=249

 Score = 155 bits (391),  Expect = 2e-46, Method: Compositional matrix adjust.
 Identities = 84/229 (37%), Positives = 133/229 (58%), Gaps = 20/229 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            E  CG +++S+ +ILTAAHC+        +      VR+G  N  + E+G E +  ++ +
Sbjct  39   EGFCGGTILSEFYILTAAHCL--------YQAKRFKVRVGDRNTEQ-EEGGEAVHEVEVV  89

Query  62   IVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNL  121
            I H ++  KE  + DIA+L ++ PITF   + P CLP +  A++ +     G V+G+G  
Sbjct  90   IKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRT  148

Query  122  YETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDS  181
            +E    S     T L+ + +P V+++ C+ S+S  IT NMFCAG+  +++   DAC+GDS
Sbjct  149  HEKGRQS-----TRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQE---DACQGDS  200

Query  182  GGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVI  230
            GGP V +  D   ++  GIVSWGEGC R GKYG YT +    +W+ + +
Sbjct  201  GGPHVTRFKDT--YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM  247


>3F6U_H Chain H, Crystal Structure Of Human Activated Protein C (Apc) 
Complexed With Ppack
Length=240

 Score = 151 bits (382),  Expect = 4e-45, Method: Compositional matrix adjust.
 Identities = 89/227 (39%), Positives = 127/227 (56%), Gaps = 16/227 (7%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            ++L CGA LI   W+LTAAHC+             +LVRLG+++  ++EK  E  + I E
Sbjct  23   KKLACGAVLIHPSWVLTAAHCMDES--------KKLLVRLGEYDLRRWEK-WELDLDIKE  73

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVA-KTLMFAGYKGRVTGWG  119
            + VHP Y+ K   + DIALLH+ +P T +  I P+CLP   +A + L  AG +  VTGWG
Sbjct  74   VFVHPNYS-KSTTDNDIALLHLAQPATLSQTIVPICLPDSGLAERELNQAGQETLVTGWG  132

Query  120  NLYETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
                    + ++   VL  I +P+V  + C +  S  +++NM CAG   + Q   DACEG
Sbjct  133  YHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMSNMVSENMLCAGILGDRQ---DACEG  189

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWM  226
            DSGGP V  +     W+ +G+VSWGEGC     YG YT + R   W+
Sbjct  190  DSGGPMV--ASFHGTWFLVGLVSWGEGCGLLHNYGVYTKVSRYLDWI  234


>1AUT_C Chain C, Human Activated Protein C
Length=250

 Score = 151 bits (382),  Expect = 5e-45, Method: Compositional matrix adjust.
 Identities = 89/227 (39%), Positives = 127/227 (56%), Gaps = 16/227 (7%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
            ++L CGA LI   W+LTAAHC+             +LVRLG+++  ++EK  E  + I E
Sbjct  23   KKLACGAVLIHPSWVLTAAHCM--------DESKKLLVRLGEYDLRRWEK-WELDLDIKE  73

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVA-KTLMFAGYKGRVTGWG  119
            + VHP Y+ K   + DIALLH+ +P T +  I P+CLP   +A + L  AG +  VTGWG
Sbjct  74   VFVHPNYS-KSTTDNDIALLHLAQPATLSQTIVPICLPDSGLAERELNQAGQETLVTGWG  132

Query  120  NLYETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEG  179
                    + ++   VL  I +P+V  + C +  S  +++NM CAG   + Q   DACEG
Sbjct  133  YHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMSNMVSENMLCAGILGDRQ---DACEG  189

Query  180  DSGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWM  226
            DSGGP V  +     W+ +G+VSWGEGC     YG YT + R   W+
Sbjct  190  DSGGPMV--ASFHGTWFLVGLVSWGEGCGLLHNYGVYTKVSRYLDWI  234


>1KIG_H Chain H, Bovine Factor Xa
Length=241

 Score = 151 bits (381),  Expect = 5e-45, Method: Compositional matrix adjust.
 Identities = 84/234 (36%), Positives = 131/234 (56%), Gaps = 20/234 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            E  CG +++++ ++LTAAHC+      K FT     VR+G  N  + E+G E    ++  
Sbjct  24   EGFCGGTILNEFYVLTAAHCLHQA---KRFT-----VRVGDRNTEQ-EEGNEMAHEVEMT  74

Query  62   IVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNL  121
            + H ++  KE  + DIA+L ++ PI F   + P CLP K  A+  +     G V+G+G  
Sbjct  75   VKHSRF-VKETYDFDIAVLRLKTPIRFRRNVAPACLPEKDWAEATLMTQKTGIVSGFGRT  133

Query  122  YETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDS  181
            +E        L + L+ + +P V++  C+ S+S  IT NMFCAG+  + +   DAC+GDS
Sbjct  134  HE-----KGRLSSTLKMLEVPYVDRSTCKLSSSFTITPNMFCAGYDTQPE---DACQGDS  185

Query  182  GGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDKTGG  235
            GGP V +  D   ++  GIVSWGEGC R GK+G YT +    +W+ K++    G
Sbjct  186  GGPHVTRFKDT--YFVTGIVSWGEGCARKGKFGVYTKVSNFLKWIDKIMKARAG  237


>5JBB_S Chain S, Crystal Structure Of Factor Ixa Variant V16i K98t Y177t 
I213v In Complex With Egr-chloromethylketone
 5JBC_S Chain S, Crystal Structure Of Factor Ixa Variant V16i K98t Y177t 
I213v In Complex With Ppack
Length=235

 Score = 143 bits (361),  Expect = 4e-42, Method: Compositional matrix adjust.
 Identities = 85/228 (37%), Positives = 123/228 (54%), Gaps = 21/228 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            +  CG S+++++WI+TAAHC+         T   I V  G+HN  + E  TE+   +  I
Sbjct  23   DAFCGGSIVNEKWIVTAAHCVE--------TGVKITVVAGEHNIEETEH-TEQKRNVIRI  73

Query  62   IVHPKYNWKEN-LNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I H  YN   N  N DIALL +  P+     + P+C+  K+     +  G  G V+GWG 
Sbjct  74   IPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFG-SGYVSGWGR  132

Query  121  LYETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGD  180
            ++    S+      VLQ + +P+V++  C  ST   IT+NMFCAGF    +   D+C+GD
Sbjct  133  VFHKGRSA-----LVLQYLRVPLVDRATCLRSTKFTITNNMFCAGF---HEGGRDSCQGD  184

Query  181  SGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKK  228
            SGGP V +    +  +  GIVSWGE C   GKYG YT + R   W+K+
Sbjct  185  SGGPHVTEVEGTS--FLTGIVSWGEECAMKGKYGIYTKVSRYVNWIKE  230


>2WPI_S Chain S, Factor Ixa Superactive Double Mutant
Length=235

 Score = 143 bits (360),  Expect = 6e-42, Method: Compositional matrix adjust.
 Identities = 84/228 (37%), Positives = 123/228 (54%), Gaps = 21/228 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            +  CG S+++++WI+TAAHC+         T   I V  G+HN  + E  TE+   +  I
Sbjct  23   DAFCGGSIVNEKWIVTAAHCVE--------TGVKITVVAGEHNIEETEH-TEQKRNVIRI  73

Query  62   IVHPKYNWKEN-LNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I H  YN   N  N DIALL +  P+     + P+C+  K+     +  G  G V+GWG 
Sbjct  74   IPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFG-SGYVSGWGR  132

Query  121  LYETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGD  180
            ++    S+      VLQ + +P+V++  C  ST   IT+NMFCAGF    +   D+C+GD
Sbjct  133  VFHKGRSA-----LVLQYLRVPLVDRATCLRSTKFTITNNMFCAGF---HEGGRDSCQGD  184

Query  181  SGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKK  228
            SGGP V +    +  +  GI+SWGE C   GKYG YT + R   W+K+
Sbjct  185  SGGPHVTEVEGTS--FLTGIISWGEECAMKGKYGIYTKVSRYVNWIKE  230


>1A0J_A Chain A, Crystal Structure Of A Non-Psychrophilic Trypsin From 
A Cold-Adapted Fish Species.
 1A0J_B Chain B, Crystal Structure Of A Non-Psychrophilic Trypsin From 
A Cold-Adapted Fish Species.
 1A0J_C Chain C, Crystal Structure Of A Non-Psychrophilic Trypsin From 
A Cold-Adapted Fish Species.
 1A0J_D Chain D, Crystal Structure Of A Non-Psychrophilic Trypsin From 
A Cold-Adapted Fish Species.
Length=223

 Score = 142 bits (358),  Expect = 8e-42, Method: Compositional matrix adjust.
 Identities = 84/229 (37%), Positives = 120/229 (52%), Gaps = 30/229 (13%)

Query  4    LCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEIIV  63
             CG SLIS  W+++AAHC            + I VRLG+HN A   +GTE+ +   ++I+
Sbjct  24   FCGGSLISSTWVVSAAHCYK----------SRIQVRLGEHNIA-VNEGTEQFIDSVKVIM  72

Query  64   HPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNLYE  123
            HP YN   NL+ DI L+ + +P +    +  V LP+   +     +G +  V+GWGNL  
Sbjct  73   HPSYN-SRNLDNDIMLIKLSKPASLNSYVSTVALPSSCAS-----SGTRCLVSGWGNL--  124

Query  124  TWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDSGG  183
              S S  + P  L+ + LPI+    C  +   +IT NMFCAGF    +   D+C+GDSGG
Sbjct  125  --SGSSSNYPDTLRCLDLPILSSSSCNSAYPGQITSNMFCAGFMEGGK---DSCQGDSGG  179

Query  184  PFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVIDK  232
            P V      N   Q G+VSWG GC +  K G YT +   R W+   +  
Sbjct  180  PVVC-----NGQLQ-GVVSWGYGCAQRNKPGVYTKVCNYRSWISSTMSS  222


>5JBA_S Chain S, Crystal Structure Of Factor Ixa Variant V16i K98t Y177t 
I212v In Complex With Ppack
Length=235

 Score = 142 bits (359),  Expect = 1e-41, Method: Compositional matrix adjust.
 Identities = 83/228 (36%), Positives = 123/228 (54%), Gaps = 21/228 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            +  CG S+++++WI+TAAHC+         T   I V  G+HN  + E  TE+   +  I
Sbjct  23   DAFCGGSIVNEKWIVTAAHCVE--------TGVKITVVAGEHNIEETEH-TEQKRNVIRI  73

Query  62   IVHPKYNWKEN-LNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I H  YN   N  N DIALL +  P+     + P+C+  K+     +  G  G V+GWG 
Sbjct  74   IPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFG-SGYVSGWGR  132

Query  121  LYETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGD  180
            ++    S+      VLQ + +P+V++  C  ST   IT+NMFCAGF    +   D+C+GD
Sbjct  133  VFHKGRSA-----LVLQYLRVPLVDRATCLRSTKFTITNNMFCAGF---HEGGRDSCQGD  184

Query  181  SGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKK  228
            SGGP V +    +  +  G++SWGE C   GKYG YT + R   W+K+
Sbjct  185  SGGPHVTEVEGTS--FLTGVISWGEECAMKGKYGIYTKVSRYVNWIKE  230


>4YZU_A Chain A, Rapid Development Of Two Factor Ixa Inhibitors From 
Hit To Lead
 4Z0K_A Chain A, Rapid Development Of Two Factor Ixa Inhibitors From 
Hit To Lead
 4ZAE_A Chain A, Development Of A Novel Class Of Potent And Selective 
Fixa Inhibitors
 5EGM_A Chain A, Development Of A Novel Tricyclic Class Of Potent And 
Selective Fixa Inhibitors
Length=235

 Score = 142 bits (357),  Expect = 2e-41, Method: Compositional matrix adjust.
 Identities = 83/228 (36%), Positives = 123/228 (54%), Gaps = 21/228 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            +  CG S+++++WI+TAAHC+         T   I V  G+HN  + E  TE+   +  I
Sbjct  23   DAFCGGSIVNEKWIVTAAHCVE--------TGVKITVVAGEHNIEETEH-TEQKRNVIRI  73

Query  62   IVHPKYNWKEN-LNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I H  YN   N  N DIALL +  P+     + P+C+  K+     +  G  G V+GWG 
Sbjct  74   IPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFG-SGYVSGWGR  132

Query  121  LYETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGD  180
            ++   +S+      VLQ + +P+V++  C  ST   I +NMFCAGF    +   D+C+GD
Sbjct  133  VFHKGASA-----LVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGF---HEGGRDSCQGD  184

Query  181  SGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKK  228
            SGGP V +    +  +  GI+SWGE C   GKYG YT + R   W+K+
Sbjct  185  SGGPHVTEVEGTS--FLTGIISWGEECAMKGKYGIYTKVSRYVNWIKE  230


>2WPH_S Chain S, Factor Ixa Superactive Triple Mutant
 2WPJ_S Chain S, Factor Ixa Superactive Triple Mutant, Nacl-soaked
 2WPK_S Chain S, Factor Ixa Superactive Triple Mutant, Ethylene Glycol-soaked
 2WPL_S Chain S, Factor Ixa Superactive Triple Mutant, Edta-soaked
Length=235

 Score = 141 bits (356),  Expect = 2e-41, Method: Compositional matrix adjust.
 Identities = 83/228 (36%), Positives = 123/228 (54%), Gaps = 21/228 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            +  CG S+++++WI+TAAHC+         T   I V  G+HN  + E  TE+   +  I
Sbjct  23   DAFCGGSIVNEKWIVTAAHCVE--------TGVKITVVAGEHNIEETEH-TEQKRNVIRI  73

Query  62   IVHPKYNWKEN-LNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I H  +N   N  N DIALL +  P+     + P+C+  K+     +  G  G V+GWG 
Sbjct  74   IPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFG-SGYVSGWGR  132

Query  121  LYETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGD  180
            ++    S+      VLQ + +P+V++  C  ST   IT+NMFCAGF    +   D+C+GD
Sbjct  133  VFHKGRSA-----LVLQYLRVPLVDRATCLRSTKFTITNNMFCAGF---HEGGRDSCQGD  184

Query  181  SGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKK  228
            SGGP V +    +  +  GI+SWGE C   GKYG YT + R   W+K+
Sbjct  185  SGGPHVTEVEGTS--FLTGIISWGEECAMKGKYGIYTKVSRYVNWIKE  230


>5JB8_S Chain S, Crystal Structure Of Factor Ixa Variant K98t In Complex 
With Egr- Chloromethylketone
 5JB9_S Chain S, Crystal Structure Of Factor Ixa K98t Variant In Complex 
With Ppack
Length=235

 Score = 140 bits (354),  Expect = 5e-41, Method: Compositional matrix adjust.
 Identities = 83/228 (36%), Positives = 122/228 (54%), Gaps = 21/228 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            +  CG S+++++WI+TAAHC+         T   I V  G+HN  + E  TE+   +  I
Sbjct  23   DAFCGGSIVNEKWIVTAAHCVE--------TGVKITVVAGEHNIEETEH-TEQKRNVIRI  73

Query  62   IVHPKYNWKEN-LNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I H  YN   N  N DIALL +  P+     + P+C+  K+     +  G  G V+GWG 
Sbjct  74   IPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFG-SGYVSGWGR  132

Query  121  LYETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGD  180
            ++    S+      VLQ + +P+V++  C  ST   I +NMFCAGF    +   D+C+GD
Sbjct  133  VFHKGRSA-----LVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGF---HEGGRDSCQGD  184

Query  181  SGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKK  228
            SGGP V +    +  +  GI+SWGE C   GKYG YT + R   W+K+
Sbjct  185  SGGPHVTEVEGTS--FLTGIISWGEECAMKGKYGIYTKVSRYVNWIKE  230


>1RFN_A Chain A, Human Coagulation Factor Ixa In Complex With P-Amino 
Benzamidine
 3LC3_A Chain A, Benzothiophene Inhibitors Of Factor Ixa
 3LC3_C Chain C, Benzothiophene Inhibitors Of Factor Ixa
 3LC5_A Chain A, Selective Benzothiophine Inhibitors Of Factor Ixa
Length=235

 Score = 140 bits (354),  Expect = 5e-41, Method: Compositional matrix adjust.
 Identities = 83/228 (36%), Positives = 122/228 (54%), Gaps = 21/228 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            +  CG S+++++WI+TAAHC+         T   I V  G+HN  + E  TE+   +  I
Sbjct  23   DAFCGGSIVNEKWIVTAAHCVE--------TGVKITVVAGEHNIEETEH-TEQKRNVIRI  73

Query  62   IVHPKYNWKEN-LNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I H  YN   N  N DIALL +  P+     + P+C+  K+     +  G  G V+GWG 
Sbjct  74   IPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFG-SGYVSGWGR  132

Query  121  LYETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGD  180
            ++    S+      VLQ + +P+V++  C  ST   I +NMFCAGF    +   D+C+GD
Sbjct  133  VFHKGRSA-----LVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGF---HEGGRDSCQGD  184

Query  181  SGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKK  228
            SGGP V +    +  +  GI+SWGE C   GKYG YT + R   W+K+
Sbjct  185  SGGPHVTEVEGTS--FLTGIISWGEECAMKGKYGIYTKVSRYVNWIKE  230


>2WPM_S Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited
Length=235

 Score = 140 bits (354),  Expect = 5e-41, Method: Compositional matrix adjust.
 Identities = 82/228 (36%), Positives = 123/228 (54%), Gaps = 21/228 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            +  CG S+++++WI+TAAHC+         T   I V  G+HN  + E  TE+   +  I
Sbjct  23   DAFCGGSIVNEKWIVTAAHCVE--------TGVKITVVAGEHNIEETEH-TEQKRNVIRI  73

Query  62   IVHPKYNWKEN-LNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I H  +N   N  N DIALL +  P+     + P+C+  K+     +  G  G V+GWG 
Sbjct  74   IPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFG-SGYVSGWGR  132

Query  121  LYETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGD  180
            ++    ++      VLQ + +P+V++  C  ST   IT+NMFCAGF    +   D+C+GD
Sbjct  133  VFHKGRAA-----LVLQYLRVPLVDRATCLRSTKFTITNNMFCAGF---HEGGRDSCQGD  184

Query  181  SGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKK  228
            SGGP V +    +  +  GI+SWGE C   GKYG YT + R   W+K+
Sbjct  185  SGGPHVTEVEGTS--FLTGIISWGEECAMKGKYGIYTKVSRYVNWIKE  230


>3KCG_H Chain H, Crystal Structure Of The Antithrombin-Factor Ixa- Pentasaccharide 
Complex
Length=235

 Score = 139 bits (351),  Expect = 1e-40, Method: Compositional matrix adjust.
 Identities = 82/228 (36%), Positives = 122/228 (54%), Gaps = 21/228 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            +  CG S+++++WI+TAAHC+         T   I V  G+HN  + E  TE+   +  I
Sbjct  23   DAFCGGSIVNEKWIVTAAHCVE--------TGVKITVVAGEHNIEETEH-TEQKRNVIRI  73

Query  62   IVHPKYNWKEN-LNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I H  YN   N  N DIALL +  P+     + P+C+  K+     +  G  G V+GWG 
Sbjct  74   IPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFG-SGYVSGWGR  132

Query  121  LYETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGD  180
            ++    S+      VLQ + +P+V++  C  ST   I +NMFCAGF    +   D+C+GD
Sbjct  133  VFHKGRSA-----LVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGF---HEGGRDSCQGD  184

Query  181  SGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKK  228
            +GGP V +    +  +  GI+SWGE C   GKYG YT + R   W+K+
Sbjct  185  AGGPHVTEVEGTS--FLTGIISWGEECAMKGKYGIYTKVSRYVNWIKE  230


>1PFX_C Chain C, Porcine Factor Ixa
 1X7A_C Chain C, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino) Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-Fluorophenyl]- 
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length=235

 Score = 138 bits (348),  Expect = 4e-40, Method: Compositional matrix adjust.
 Identities = 83/228 (36%), Positives = 123/228 (54%), Gaps = 21/228 (9%)

Query  2    ELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEI  61
            +  CG S+I+++W++TAAHCI   P  K      I V  G++N  + E  TE+   +   
Sbjct  23   DAFCGGSIINEKWVVTAAHCI--EPGVK------ITVVAGEYNTEETEP-TEQRRNVIRA  73

Query  62   IVHPKYNWKEN-LNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            I H  YN   N  + DIALL +  P+T    + P+C+  K+     +  G  G V+GWG 
Sbjct  74   IPHHSYNATVNKYSHDIALLELDEPLTLNSYVTPICIADKEYTNIFLKFG-SGYVSGWGR  132

Query  121  LYETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGD  180
            ++    S+     T+LQ + +P+V++  C  ST   I  NMFCAGF    +   D+C+GD
Sbjct  133  VFNRGRSA-----TILQYLKVPLVDRATCLRSTKFTIYSNMFCAGF---HEGGKDSCQGD  184

Query  181  SGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKK  228
            SGGP V +    +  +  GI+SWGE C   GKYG YT + R   W+K+
Sbjct  185  SGGPHVTEVEGTS--FLTGIISWGEECAVKGKYGIYTKVSRYVNWIKE  230


>3VEQ_B Chain B, A Binary Complex Betwwen Bovine Pancreatic Trypsin And 
A Engineered Mutant Trypsin Inhibitor
Length=223

 Score = 136 bits (342),  Expect = 2e-39, Method: Compositional matrix adjust.
 Identities = 81/227 (36%), Positives = 115/227 (51%), Gaps = 30/227 (13%)

Query  4    LCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEIIV  63
             CG SLI+ +W+++AAHC            + I VRLG+ N    E G E+ ++  + IV
Sbjct  24   FCGGSLINSQWVVSAAHCYK----------SGIQVRLGEDNINVVE-GNEQFISASKSIV  72

Query  64   HPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNLYE  123
            HP YN    LN DI L+ ++   +    +  V LPT     +   AG +  ++GWGN   
Sbjct  73   HPSYN-SNTLNNDIMLIKLKSAASLNSRVASVSLPT-----SCASAGTQCLISGWGNT--  124

Query  124  TWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDSGG  183
               SS  S P VL+ +  PI+    C+ +   +IT NMFCAG+    +   D+C+GDSGG
Sbjct  125  --KSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGK---DSCQGDSGG  179

Query  184  PFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVI  230
            P V            GIVSWG GC +  K G YT +     W+K+ I
Sbjct  180  PVVCAGKLQ------GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI  220


>1TAW_A Chain A, Bovine Trypsin Complexed To Appi
 1ZR0_A Chain A, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor 
Pathway Inhibitor-2 With Bovine Trypsin
 1ZR0_C Chain C, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor 
Pathway Inhibitor-2 With Bovine Trypsin
Length=223

 Score = 136 bits (342),  Expect = 2e-39, Method: Compositional matrix adjust.
 Identities = 80/227 (35%), Positives = 115/227 (51%), Gaps = 30/227 (13%)

Query  4    LCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEIIV  63
             CG SLI+ +W+++AAHC            + I VRLG+ N    E G E+ ++  + IV
Sbjct  24   FCGGSLINSQWVVSAAHCYK----------SGIQVRLGEDNINVVE-GNEQFISASKSIV  72

Query  64   HPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNLYE  123
            HP YN    LN DI L+ ++   +    +  + LPT     +   AG +  ++GWGN   
Sbjct  73   HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPT-----SCASAGTQCLISGWGNT--  124

Query  124  TWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDSGG  183
               SS  S P VL+ +  PI+    C+ +   +IT NMFCAG+    +   D+C+GDSGG
Sbjct  125  --KSSGTSYPDVLKCLKAPILSTSSCKSAYPGQITSNMFCAGYLEGGK---DSCQGDSGG  179

Query  184  PFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVI  230
            P V            GIVSWG GC +  K G YT +     W+K+ I
Sbjct  180  PVVCSGKLQ------GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI  220


>1Y59_T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific 
Inhibitor In Complex With Bovine Trypsin Mutant
 1Y5A_T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific 
Inhibitor In Complex With Bovine Trypsin Mutant
 1Y5B_T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific 
Inhibitor In Complex With Bovine Trypsin Mutant
 1Y5U_T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific 
Inhibitor In Complex With Bovine Trypsin Mutant
Length=223

 Score = 135 bits (341),  Expect = 3e-39, Method: Compositional matrix adjust.
 Identities = 80/227 (35%), Positives = 115/227 (51%), Gaps = 30/227 (13%)

Query  4    LCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEIIV  63
             CG SLI+ +W+++AAHC            + I VRLG+ N    E G E+ ++  + IV
Sbjct  24   FCGGSLINSQWVVSAAHCYK----------SGIQVRLGEDNINVVE-GNEQFISASKSIV  72

Query  64   HPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNLYE  123
            HP YN  E  N DI L+ ++   +    +  + LPT     +   AG +  ++GWGN   
Sbjct  73   HPSYN-SETYNNDIMLIKLKSAASLNSRVASISLPT-----SCASAGTQCLISGWGNT--  124

Query  124  TWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDSGG  183
               SS  S P VL+ +  PI+    C+ +   +IT NMFCAG+    +   D+C+GDSGG
Sbjct  125  --KSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGK---DSCQGDSGG  179

Query  184  PFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVI  230
            P V            GIVSWG GC +  K G YT +     W+K+ I
Sbjct  180  PVVCSGKLQ------GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI  220


>3OTJ_E Chain E, A Crystal Structure Of Trypsin Complexed With Bpti (Bovine 
Pancreatic Trypsin Inhibitor) By X-RayNEUTRON JOINT REFINEMENT
Length=223

 Score = 135 bits (341),  Expect = 3e-39, Method: Compositional matrix adjust.
 Identities = 80/227 (35%), Positives = 115/227 (51%), Gaps = 30/227 (13%)

Query  4    LCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEIIV  63
             CG SLI+ +W+++AAHC            + I VRLG+ N    E G E+ ++  + IV
Sbjct  24   FCGGSLINSQWVVSAAHCYK----------SGIQVRLGEDNINVVE-GNEQFISASKSIV  72

Query  64   HPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNLYE  123
            HP YN    LN DI L+ ++   +    +  + LPT     +   AG +  ++GWGN   
Sbjct  73   HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPT-----SCASAGTQCLISGWGNT--  124

Query  124  TWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDSGG  183
               SS  S P VL+ +  PI+    C+ +   +IT NMFCAG+    +   D+C+GDSGG
Sbjct  125  --KSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGK---DSCQGDSGG  179

Query  184  PFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVI  230
            P V            GIVSWG GC +  K G YT +     W+K+ I
Sbjct  180  PVVCSGKLQ------GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI  220


>1TAB_E Chain E, Structure Of The Trypsin-Binding Domain Of Bowman-Birk 
Type Protease Inhibitor And Its Interaction With Trypsin
 1TPA_E Chain E, The Geometry Of The Reactive Site And Of The Peptide 
Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors
 2PTC_E Chain E, The Geometry Of The Reactive Site And Of The Peptide 
Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors
 1PPC_E Chain E, Geometry Of Binding Of The Benzamidine-and Arginine-based 
Inhibitors N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-amidinophenylalanyl- 
Piperidine (napap) And (2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4- 
Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine 
Carboxylic Acid (mqpa) To Human 
Alpha-thrombin: X-ray Crystallographic Determination Of The 
Napap-trypsin Complex And Modeling Of Napap- Thrombin And Mqpa-thrombin
 1PPE_E Chain E, The Refined 2.0 Angstroms X-Ray Crystal Structure Of 
The Complex Formed Between Bovine Beta-Trypsin And Cmti-I, 
A Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima): Topological 
Similarity Of The Squash Seed Inhibitors With The 
Carboxypeptidase A Inhibitor From Potatoes
 1PPH_E Chain E, Geometry Of Binding Of The Nalpha-Tosylated Piperidides 
Of M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To 
Thrombin And Trypsin: X- Ray Crystal Structures Of Their Trypsin 
Complexes And Modeling Of Their Thrombin Complexes
 1SMF_E Chain E, Studies On An Artificial Trypsin Inhibitor Peptide Derived 
From The Mung Bean Inhibitor
 1JRT_A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
 1JRS_A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
 1CE5_A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzamidine
 2BZA_A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzylamine
 1QCP_A Chain A, Crystal Structure Of The Rwj-51084 Bovine Pancreatic 
Beta- Trypsin At 1.8 A
 1SBW_A Chain A, Crystal Structure Of Mung Bean Inhibitor Lysine Active 
Fragment Complex With Bovine Beta-Trypsin At 1.8a Resolution
 1YYY_1 Chain 1, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
 1SFI_A Chain A, High Resolution Structure Of A Potent, Cyclic Protease 
Inhibitor From Sunflower Seeds
 1TIO_A Chain A, High Packing Density Form Of Bovine Beta-trypsin In 
Cyclohexane
 2TIO_A Chain A, Low Packing Density Form Of Bovine Beta-Trypsin In Cyclohexane
 2BTC_E Chain E, Bovine Trypsin In Complex With Squash Seed Inhibitor 
(Cucurbita Pepo Trypsin Inhibitor Ii)
 3BTE_E Chain E, The Crystal Structures Of The Complexes Between Bovine 
Beta-Trypsin And Ten P1 Variants Of Bpti.
 3BTD_E Chain E, The Crystal Structures Of The Complexes Between The 
Bovine Beta- Trypsin And Ten P1 Variants Of Bpti.
 3BTF_E Chain E, The Crystal Structures Of The Complexes Between Bovine 
Beta- Trypsin And Ten P1 Variants Of Bpti.
 3BTG_E Chain E, The Crystal Structures Of The Complexes Between Bovine 
Beta- Trypsin And Ten P1 Variants Of Bpti
 3BTH_E Chain E, The Crystal Structures Of The Complexes Between Bovine 
Beta- Trypsin And Ten P1 Variants Of Bpti
 3BTK_E Chain E, The Crystal Structures Of The Complexes Between Bovine 
Beta- Trypsin And Ten P1 Variants Of Bpti
 3BTM_E Chain E, The Crystal Structures Of The Complexes Between Bovine 
Beta- Trypsin And Ten P1 Variants Of Bpti
 3BTQ_E Chain E, The Crystal Structures Of The Complexes Between Bovine 
Beta- Trypsin And Ten P1 Variants Of Bpti
 3BTT_E Chain E, The Crystal Structures Of The Complexes Between Bovine 
Beta- Trypsin And Ten P1 Variants Of Bpti
 3BTW_E Chain E, The Crystal Structures Of The Complexes Between Bovine 
Beta- Trypsin And Ten P1 Variants Of Bpti
 1QBN_A Chain A, Bovine Trypsin 2-[amino(Imino)methyl]-2-Hydroxyphenoxy]-6- 
[3-(4,5-Dihydro-1h-Imidazol-2-Yl)phenoxy]pyridine-4- 
Carboxylic Acid (Zk-806688) Complex
 1QBO_A Chain A, Bovine Trypsin 7-[[6-[[1-(1-iminoethyl)piperidin-4-yl]oxy]-2-methyl- 
Benzimidazol-1-yl]methyl]naphthalene-2-carboximidamid 
Zk-806711 Inhibitor Complex
 1QB9_A Chain A, Bovine Trypsin 7-[[2-[[1-(1-iminoethyl)piperidin-4-yl]oxy]-9h- 
Carbozol-9-yl] Methyl]naphthalene-2-carboximidamide 
(zk-806450) Complex
 1QB1_A Chain A, Bovine Trypsin With 1-[2-[5-[amino(imino)methyl]-2- 
Hydroxyphenoxy]-6-[3-(4,5-dihydro-1-methyl-1h-imidazol-2- Yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic 
Acid (zk- 806974)
 1QB6_A Chain A, Bovine Trypsin 3,3'-[3,5-Difluoro-4-Methyl-2, 6- Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) 
(Zk- 805623) Complex
 1QA0_A Chain A, Bovine Trypsin 2-Aminobenzimidazole Complex
 1F2S_E Chain E, Crystal Structure Of The Complex Formed Between Bovine 
Beta- Trypsin And Mcti-A, A Trypsin Inhibitor Of Squash Family 
At 1.8 A Resolution
 1D6R_A Chain A, Crystal Structure Of Cancer Chemopreventive Bowman-Birk 
Inhibitor In Ternary Complex With Bovine Trypsin At 2.3 
A Resolution. Structural Basis Of Janus-Faced Serine Protease 
Inhibitor Specificity
 1C9T_A Chain A, Complex Of Bdellastasin With Bovine Trypsin
 1C9T_B Chain B, Complex Of Bdellastasin With Bovine Trypsin
 1C9T_C Chain C, Complex Of Bdellastasin With Bovine Trypsin
 1C9T_D Chain D, Complex Of Bdellastasin With Bovine Trypsin
 1C9T_E Chain E, Complex Of Bdellastasin With Bovine Trypsin
 1C9T_F Chain F, Complex Of Bdellastasin With Bovine Trypsin
 1QL7_A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine 
Trypsin
 1QL8_A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine 
Trypsin
 1G9I_E Chain E, Crystal Structure Of Beta-Trysin Complex In Cyclohexane
 1EJM_A Chain A, Crystal Structure Of The Bpti Ala16leu Mutant In Complex 
With Bovine Trypsin
 1EJM_C Chain C, Crystal Structure Of The Bpti Ala16leu Mutant In Complex 
With Bovine Trypsin
 1EJM_E Chain E, Crystal Structure Of The Bpti Ala16leu Mutant In Complex 
With Bovine Trypsin
 1JIR_A Chain A, Crystal Structure Of Trypsin Complex With Amylamine 
In Cyclohexane
 1J8A_A Chain A, Crystal Structure Of Benzamidine Inhibited Bovine Pancreatic 
Trypsin At 105k To 1.21a Resolution From Laboratory 
Source With High Number Of Waters Modelled
 1G36_A Chain A, Trypsin Inhibitor Complex
 1K1P_A Chain A, Bovine Trypsin-Inhibitor Complex
 1K1O_A Chain A, Bovine Trypsin-Inhibitor Complex
 1K1N_A Chain A, Bovine Trypsin-Inhibitor Complex
 1K1M_A Chain A, Bovine Trypsin-Inhibitor Complex
 1K1L_A Chain A, Bovine Trypsin-Inhibitor Complex
 1K1J_A Chain A, Bovine Trypsin-Inhibitor Complex
 1K1I_A Chain A, Bovine Trypsin-Inhibitor Complex
 1EB2_A Chain A, Trypsin Inhibitor Complex (Bpo)
 1GJ6_A Chain A, Engineering Inhibitors Highly Selective For The S1 Sites 
Of Ser190 Trypsin-Like Serine Protease Drug Targets
 1N6X_A Chain A, Rip-Phasing On Bovine Trypsin
 1N6Y_A Chain A, Rip-Phasing On Bovine Trypsin
 1OYQ_A Chain A, Trypsin Inhibitor Complex
 1O2H_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O2I_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O2J_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O2K_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O2L_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O2M_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O2N_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-directed Serine Protease Inhibitors
 1O2O_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O2P_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O2Q_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O2R_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O2S_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O2T_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O2U_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O2V_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O2W_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O2X_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O2Y_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O2Z_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O30_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O31_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-directed Serine Protease Inhibitors
 1O32_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O33_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O34_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O35_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-directed Serine Protease Inhibitors
 1O36_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-directed Serine Protease Inhibitors
 1O37_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O38_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O39_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O3A_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O3B_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O3C_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O3D_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O3E_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O3F_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O3G_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O3H_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O3I_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O3J_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O3K_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O3L_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O3M_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-directed Serine Protease Inhibitors
 1O3N_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-Directed Serine Protease Inhibitors
 1O3O_A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating 
Binding Of Active Site-directed Serine Protease Inhibitors
 1NC6_A Chain A, Potent, Small Molecule Inhibitors Of Human Mast Cell 
Tryptase. Anti-Asthmatic Action Of A Dipeptide-Based Transition 
State Analogue Containing Benzothiazole Ketone
 1P2I_A Chain A, Structural Consequences Of Accommodation Of Four Non- 
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine Trypsin 
And Chymotrypsin
 1P2J_A Chain A, Structural Consequences Of Accommodation Of Four Non- 
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine Trypsin 
And Chymotrypsin
 1P2K_A Chain A, Structural Consequences Of Accommodation Of Four Non- 
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine Trypsin 
And Chymotrypsin
 1OX1_A Chain A, Crystal Structure Of The Bovine Trypsin Complex With 
A Synthetic 11 Peptide Inhibitor
 1RXP_A Chain A, Structure Of Trypsin (Orthorhombic) With 1-(4-Tert- 
Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino- Propyl)-4-Oxo-Azetidine-2-Carboxylic 
Acid
 1S0Q_A Chain A, Native Bovine Pancreatic Trypsin
 1S0R_A Chain A, Bovine Pancreatic Trypsin Inhibited With Benzamidine 
At Atomic Resolution
 2A7H_A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular 
Crystallography, Part Iii- The Optimal Data Collection Wavelength
 1TX7_A Chain A, Bovine Trypsin Complexed With P- Amidinophenylmethylphosphinic 
Acid (Ampa)
 2BLV_A Chain A, Trypsin Before A High Dose X-Ray "burn"
 2BLW_A Chain A, Trypsin After A High Dose X-Ray "burn"
 1TX8_A Chain A, Bovine Trypsin Complexed With Amso
 1Y3U_A Chain A, Trypsin Inhibitor Complex
 1Y3V_A Chain A, Trypsin Inhibitor Complex
 1Y3W_A Chain A, Trypsin Inhibitor Complex
 1Y3X_A Chain A, Trypsin Inhibitor Complex
 1Y3Y_A Chain A, Trypsin Inhibitor Complex
 1YP9_A Chain A, Trypsin Inhibitor Complex
 2AYW_A Chain A, Crystal Structure Of The Complex Formed Between Trypsin 
And A Designed Synthetic Highly Potent Inhibitor In The 
Presence Of Benzamidine At 0.97 A Resolution
 2FI3_E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser, Cys38->ser) 
In Complex With Trypsin
 2FX4_A Chain A, Bovine Trypsin Bound By 4-piperidinebutyrate To Make 
Acylenzyme Complex
 2FX6_A Chain A, Bovine Trypsin Complexed With 2-Aminobenzamidazole
 2AGE_X Chain X, Succinyl-Aapr-Trypsin Acyl-Enzyme At 1.15 A Resolution
 2AGG_X Chain X, Succinyl-Aapk-Trypsin Acyl-Enzyme At 1.28 A Resolution
 2AGI_X Chain X, The Leupeptin-Trypsin Covalent Complex At 1.14 A Resolution
 2AH4_X Chain X, Guanidinobenzoyl-Trypsin Acyl-Enzyme At 1.13 A Resolution
 2G5N_A Chain A, Indole-Amidine Complexes With Bovine Trypsin
 2G5V_A Chain A, Indole-Amidine Complexes With Bovine Trypsin
 2G8T_A Chain A, Indole-Amidine Complexes With Bovine Trypsin
 2F3C_E Chain E, Crystal Structure Of Infestin 1, A Kazal-Type Serineprotease 
Inhibitor, In Complex With Trypsin
 2G81_E Chain E, Crystal Structure Of The Bowman-Birk Inhibitor From 
Vigna Unguiculata Seeds In Complex With Beta-Trypsin At 1.55 
Angstrons Resolution
 2G55_A Chain A, Anomalous Substructure Of Trypsin (P3121)
 2OTV_A Chain A, Crystal Structure Of The Complex Formed Between Bovine 
Trypsin And Nicotinamide At 1.56 A Resolution
 2J9N_A Chain A, Robotically Harvested Trypsin Complexed With Benzamidine 
Containing Polypeptide Mediated Crystal Contacts
 2OXS_A Chain A, Crytal Structure Of The Trypsin Complex With Benzamidine 
At High Temperature (35 C)
 2UUY_A Chain A, Structure Of A Tick Tryptase Inhibitor In Complex With 
Bovine Trypsin
 2ILN_A Chain A, Crystal Structure Of The Bowman-Birk Inhibitor From 
Snail Medic Seeds In Complex With Bovine Trypsin
 2ILN_B Chain B, Crystal Structure Of The Bowman-Birk Inhibitor From 
Snail Medic Seeds In Complex With Bovine Trypsin
 2CMY_A Chain A, Crystal Complex Between Bovine Trypsin And Veronica 
Hederifolia Trypsin Inhibitor
 1AQ7_A Chain A, Trypsin With Inhibitor Aeruginosin 98-b
 1AUJ_A Chain A, Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor
 1AZ8_A Chain A, Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor
 1BJU_A Chain A, Beta-Trypsin Complexed With Acpu
 1BJV_A Chain A, Beta-Trypsin Complexed With Appu
 1GBT_A Chain A, Structure Of An Acyl-Enzyme Intermediate During Catalysis: 
(Guanidinobenzoyl) Trypsin
 1MAX_A Chain A, Beta-Trypsin Phosphonate Inhibited
 1MAY_A Chain A, Beta-Trypsin Phosphonate Inhibited
 1MTS_A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine 
Trypsin
 1MTU_A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine 
Trypsin
 1MTV_A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine 
Trypsin
 1MTW_A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine 
Trypsin
 1TLD_A Chain A, Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms 
Resolution In A Crystal Form With Low Molecular Packing 
Density. Active Site Geometry, Ion Pairs And Solvent Structure
 1TPO_A Chain A, The Geometry Of The Reactive Site And Of The Peptide 
Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors
 1TPP_A Chain A, The Geometry Of The Reactive Site And Of The Peptide 
Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors
 1TPS_A Chain A, Atomic Structure Of The Trypsin-A90720a Complex: A Unified 
Approach To Structure And Function
 1TYN_A Chain A, Atomic Structure Of The Trypsin-cyclotheonamide A Complex: 
Lessons For The Design Of Serine Protease Inhibitors
 1XUF_A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
 1XUG_A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
 1XUH_A Chain A, Trypsin-Keto-Babim-Co+2, Ph 8.2
 1XUI_A Chain A, Trypsin-Keto-Babim, Zn+2-Free, Ph 8.2
 1XUJ_A Chain A, Trypsin-Keto-Babim-Zn+2, Ph 8.2
 1XUK_A Chain A, Trypsin-Babim-Sulfate, Ph 5.9
 2PLX_A Chain A, Trypsin Complexed To A Synthetic Peptide From Veronica 
Hederifolia
 2PTN_A Chain A, On The Disordered Activation Domain In Trypsinogen. 
Chemical Labelling And Low-Temperature Crystallography
 3PTB_A Chain A, The Geometry Of The Reactive Site And Of The Peptide 
Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors
 3PTN_A Chain A, On The Disordered Activation Domain In Trypsinogen. 
Chemical Labelling And Low-Temperature Crystallography
 1C1N_A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 1C1O_A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 1C1P_A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 1C1Q_A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 1C1R_A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 1C1T_A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 1C2D_A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 1C2E_A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 1C2F_A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 1C2G_A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 1C2H_A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 1C2I_A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 1C2J_A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 1C2K_A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 1C2L_A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 1C2M_A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 1C5P_A Chain A, Structural Basis For Selectivity Of A Small Molecule, 
S1- Binding, Sub-Micromolar Inhibitor Of Urokinase Type Plasminogen 
Activator
 1C5Q_A Chain A, Structural Basis For Selectivity Of A Small Molecule, 
S1- Binding, Sub-Micromolar Inhibitor Of Urokinase Type Plasminogen 
Activator
 1C5R_A Chain A, Structural Basis For Selectivity Of A Small Molecule, 
S1- Binding, Sub-Micromolar Inhibitor Of Urokinase Type Plasminogen 
Activator
 1C5S_A Chain A, Structural Basis For Selectivity Of A Small Molecule, 
S1- Binding, Sub-Micromolar Inhibitor Of Urokinase Type Plasminogen 
Activator
 1C5T_A Chain A, Structural Basis For Selectivity Of A Small Molecule, 
S1- Binding, Sub-Micromolar Inhibitor Of Urokinase Type Plasminogen 
Activator
 1C5U_A Chain A, Structural Basis For Selectivity Of A Small Molecule, 
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type Plasminogen 
Activator
 1C5V_A Chain A, Structural Basis For Selectivity Of A Small Molecule, 
S1- Binding, Sub-Micromolar Inhibitor Of Urokinase Type Plasminogen 
Activator
 1GHZ_A Chain A, A Novel Serine Protease Inhibition Motif Involving A 
Multi- Centered Short Hydrogen Bonding Network At The Active 
Site
 1GI0_A Chain A, A Novel Serine Protease Inhibition Motif Involving A 
Multi-Centered Short Hydrogen Bonding Network At The Active 
Site
 1GI1_A Chain A, A Novel Serine Protease Inhibition Motif Involving A 
Multi- Centered Short Hydrogen Bonding Network At The Active 
Site
 1GI2_A Chain A, A Novel Serine Protease Inhibition Motif Involving A 
Multi- Centered Short Hydrogen Bonding Network At The Active 
Site
 1GI3_A Chain A, A Novel Serine Protease Inhibition Motif Involving A 
Multi- Centered Short Hydrogen Bonding Network At The Active 
Site
 1GI4_A Chain A, A Novel Serine Protease Inhibition Motif Involving A 
Multi- Centered Short Hydrogen Bonding Network At The Active 
Site
 1GI5_A Chain A, A Novel Serine Protease Inhibition Motif Involving A 
Multi- Centered Short Hydrogen Bonding Network At The Active 
Site
 1GI6_A Chain A, A Novel Serine Protease Inhibition Motif Involving A 
Multi- Centered Short Hydrogen Bonding Network At The Active 
Site
 2O9Q_A Chain A, The Crystal Structure Of Bovine Trypsin Complexed With 
A Small Inhibition Peptide Orb2k
 2QN5_T Chain T, Crystal Structure And Functional Study Of The Bowman-Birk 
Inhibitor From Rice Bran In Complex With Bovine Trypsin
 2QYI_A Chain A, Crystal Structure Of A Binary Complex Between An Engineered 
Trypsin Inhibitor And Bovine Trypsin
 2QYI_C Chain C, Crystal Structure Of A Binary Complex Between An Engineered 
Trypsin Inhibitor And Bovine Trypsin
 2ZDK_A Chain A, Exploring Trypsin S3 Pocket
 2ZDL_A Chain A, Exploring Trypsin S3 Pocket
 2ZDM_A Chain A, Exploring Trypsin S3 Pocket
 2ZDN_A Chain A, Exploring Trypsin S3 Pocket
 2ZFS_A Chain A, Exploring Trypsin S3 Pocket
 2ZFT_A Chain A, Exploring Trypsin S3 Pocket
 2ZHD_A Chain A, Exploring Trypsin S3 Pocket
 3D65_E Chain E, Crystal Structure Of Textilinin-1, A Kunitz-Type Serine 
Protease Inhibitor From The Australian Common Brown Snake 
Venom, In Complex With Trypsin
 3E8L_A Chain A, The Crystal Structure Of The Double-headed Arrowhead 
Protease Inhibitor A In Complex With Two Trypsins
 3E8L_B Chain B, The Crystal Structure Of The Double-headed Arrowhead 
Protease Inhibitor A In Complex With Two Trypsins
 2ZQ1_A Chain A, Exploring Trypsin S3 Pocket
 2ZQ2_A Chain A, Exploring Trypsin S3 Pocket
 3ITI_A Chain A, Structure Of Bovine Trypsin With The Mad Triangle B3c
 3GY2_A Chain A, A Comparative Study On The Inhibition Of Bovine Beta-Trypsin 
Benzamidines Diminazene And Pentamidine By X-Ray Crystallog 
Itc
 3GY3_A Chain A, A Comparative Study On The Inhibition Of Bovine Beta-Trypsin 
Benzamidines Diminazene And Pentamidine By X-Ray Crystallog 
Itc
 3GY4_A Chain A, A Comparative Study On The Inhibition Of Bovine Beta-Trypsin 
Benzamidines Diminazene And Pentamidine By X-Ray Crystallog 
Itc
 3GY5_A Chain A, A Comparative Study On The Inhibition Of Bovine Beta-Trypsin 
Benzamidines Diminazene And Pentamidine By X-Ray Crystallog 
Itc
 3GY6_A Chain A, A Comparative Study On The Inhibition Of Bovine Beta-Trypsin 
Bis-Benzamidines Diminazene And Pentamidine
 3GY7_A Chain A, A Comparative Study On The Inhibition Of Bovine Beta-Trypsin 
Benzamidines Diminazene And Pentamidine By X-Ray Crystallog 
Itc
 3GY8_A Chain A, A Comparative Study On The Inhibition Of Bovine Beta-Trypsin 
Benzamidines Diminazene And Pentamidine By X-Ray Crystallog 
Itc
 3AAS_A Chain A, Bovine Beta-Trypsin Bound To Meta-Guanidino Schiff Base 
Copper (Ii) Chelate
 3AAU_A Chain A, Bovine Beta-Trypsin Bound To Meta-Diguanidino Schiff 
Base Copper (Ii) Chelate
 3AAV_A Chain A, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base 
Copper (Ii) Chelate
 3AAV_B Chain B, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base 
Copper (Ii) Chelate
 3M35_A Chain A, Trypsin In Complex With The Inhibitor 1-[3-(Aminomethyl) 
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3- 
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
 3MFJ_A Chain A, Bovine Trypsin At 0.8 A Resolution, Restrained Refinement
 3MI4_A Chain A, Bovine Trypsin At 0.8 A Resolution, Non-Restrained Refinemen
 3I29_A Chain A, Crystal Structure Of A Binary Complex Between An Mutant 
Trypsin Inhibitor With Bovine Trypsin
 3A7T_A Chain A, Crystal Structure Of Trypsin Complexed With 4-Formylbenzimidamide
 3A7V_A Chain A, Crystal Structure Of Trypsin Complexed With 3-Formylbenzimidamide
 3A7W_A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((Tetrahydro-2h- 
Pyran-2-Yloxyimino)methyl)benzimidamide (Soaking 
4hours)
 3A7X_A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4- 
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 45seconds)
 3A7Y_A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((1-Methylpiperidin- 
3-Yloxyimino)methyl)benzimidamide (Soaking 
2hours)
 3A7Z_A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((1-Methylpiperidin- 
4-Yloxyimino)methyl)benzimidamide (Soaking 
3hours)
 3A80_A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4- 
Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic Acid (Soaking 
40seconds)
 3A81_A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2- 
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 8 Hours)
 3A82_A Chain A, Crystal Structure Of Trypsin Complexed With Pre-Synthesized 
(E)-2-(4- Carbamimidoylbenzylideneaminooxy)acetic Acid
 3A83_A Chain A, Crystal Structure Of Trypsin Complexed With Pre-Synthesized 
(E)-4-((2- Nicotinoylhydrazono)methyl)benzimidamide
 3A84_A Chain A, Crystal Structure Of Trypsin Complexed With(E)-2-(4- 
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 5 Seconds)
 3A85_A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4- 
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 15 Seconds)
 3A86_A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4- 
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 30 Seconds)
 3A87_A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2- 
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 5 Minutes)
 3A88_A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2- 
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 30 Minutes)
 3A89_A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2- 
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 4 Hours)
 3A8A_A Chain A, Crystal Structure Of Trypsin Complexed With 4-Formylbenzimidamide 
And Aniline
 3A8B_A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((4- 
Bromophenylimino)methyl)benzimidamide
 3A8C_A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4- 
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking With 
Mixture Of [(E)-2-(4-Carbamimidoylbenzylideneaminooxy)acetic 
Acid] And [(E)-2- (4-Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic 
Acid])
 3A8D_A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4- 
Carbamimidoylbenzylideneaminooxy)acetic Acid (Under Aniline-Free 
Condition)
 3LJJ_A Chain A, Bovine Trypsin In Complex With Ub-Thr 10
 3LJO_A Chain A, Bovine Trypsin In Complex With Ub-Thr 11
 2XTT_B Chain B, Bovine Trypsin In Complex With Evolutionary Enhanced 
Schistocerca Gregaria Protease Inhibitor 1 (Sgpi-1-P02)
 3NK8_A Chain A, Trypsin In Complex With Fluorine-Containing Fragment
 3NKK_A Chain A, Trypsin In Complex With Fluorine Containing Fragment
 3M7Q_A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine 
Protease Inhibitor-1 From The Caribbean Sea Anemone Stichodactyla 
Helianthus In Complex With Bovine Pancreatic Trypsin
 3RDZ_A Chain A, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom 
Resolution
 3RDZ_B Chain B, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom 
Resolution
 3ATI_A Chain A, Crystal Structure Of Trypsin Complexed With (3-Methoxyphenyl) 
Methanamine
 3ATK_A Chain A, Crystal Structure Of Trypsin Complexed With Cycloheptanamine
 3ATL_A Chain A, Crystal Structure Of Trypsin Complexed With Benzamidine
 3ATM_A Chain A, Crystal Structure Of Trypsin Complexed With 2-(1h-Indol-3-Yl) 
Ethanamine
 3RXA_A Chain A, Crystal Structure Of Trypsin Complexed With Cycloheptanamine
 3RXB_A Chain A, Crystal Structure Of Trypsin Complexed With 4-Guanidinobutanoic 
Acid
 3RXC_A Chain A, Crystal Structure Of Trypsin Complexed With 2-Aminopyridine
 3RXD_A Chain A, Crystal Structure Of Trypsin Complexed With (3-Methoxyphenyl) 
Methanamine
 3RXE_A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide
 3RXF_A Chain A, Crystal Structure Of Trypsin Complexed With 4-Aminopyridine
 3RXG_A Chain A, Crystal Structure Of Trypsin Complexed With 4-Aminocyclohexanol
 3RXH_A Chain A, Crystal Structure Of Trypsin Complexed With 2-(1h-Imidazol-4-Yl) 
Ethanamine
 3RXI_A Chain A, Crystal Structure Of Trypsin Complexed With 2-(1h-Indol-3-Yl) 
Ethanamine
 3RXJ_A Chain A, Crystal Structure Of Trypsin Complexed With 4-Guanidinobenzoic 
Acid
 3RXK_A Chain A, Crystal Structure Of Trypsin Complexed With Methyl 4-Amino-1-Methyl- 
Pyrrolidine-2-Carboxylate
 3RXL_A Chain A, Crystal Structure Of Trypsin Complexed With (2,5-Dimethyl-3-Furyl) 
Methanamine
 3RXM_A Chain A, Crystal Structure Of Trypsin Complexed With [2-(2-Thienyl)thiazol-4- 
Yl]methanamine
 3RXO_A Chain A, Crystal Structure Of Trypsin Complexed With (3-Pyrrol-1-Ylphenyl) 
Methanamine
 3RXP_A Chain A, Crystal Structure Of Trypsin Complexed With (1,5-Dimethylpyrazol-3- 
Yl)methanamine
 3RXQ_A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide 
(F01 And F05, Cocktail Experiment)
 3RXR_A Chain A, Crystal Structure Of Trypsin Complexed With Cycloheptanamine 
(F01 And F03, Cocktail Experiment)
 3RXS_A Chain A, Crystal Structure Of Trypsin Complexed With (3-Methoxyphenyl) 
Methanamine (F04 And A06, Cocktail Experiment)
 3RXT_A Chain A, Crystal Structure Of Trypsin Complexed With (3-Methoxyphenyl) 
Methanamin (F04 And F03, Cocktail Experiment)
 3RXU_A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide 
(F05 And A06, Cocktail Experiment)
 3RXV_A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide 
(F05 And F03, Cocktail Experiment)
 3T25_A Chain A, Tmao-Grown Orthorhombic Trypsin (Bovine)
 3T26_A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Sarcosine
 3T27_A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Betaine
 3T28_A Chain A, Tmao-Grown Trypsin (Bovine)-Previously Unreported Tetragonal 
Crystal Form
 3T29_A Chain A, Tmao-Grown Trigonal Trypsin (Bovine)
 4AB8_A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
 4AB9_A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
 4ABA_A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
 4ABB_A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
 4ABD_A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
 4ABE_A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
 4ABF_A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
 4ABG_A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
 4ABH_A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
 4ABI_A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified 
Bowman-Birk Inhibitor (Pta)sfti-1(1,14), That Was 1,4- Disubstituted 
With A 1,2,3-Trizol To Mimic A Trans Amide Bond
 4ABJ_A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified 
Bowman-Birk Inhibitor (Ica)sfti-1(1,14), That Was 1,5- Disubstituted 
With 1,2,3-Trizol To Mimic A Cis Amide Bond
 3VPK_A Chain A, Crystal Structure Of 6-guanidinohexanoyl Trypsin
 3UNR_A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In 
Trypsin At 1.2a Resolution
 3RU4_T Chain T, Crystal Structure Of The Bowman-Birk Serine Protease 
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
 1C1S_A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition 
Of Serine Proteases
 4I8G_A Chain A, Bovine Trypsin At 0.8 Resolution
 4I8H_A Chain A, Bovine Trypsin At 0.75 Resolution
 4I8J_A Chain A, Bovine Trypsin At 0.87 A Resolution
 4I8K_A Chain A, Bovine Trypsin At 0.85 Resolution
 4I8L_A Chain A, Bovine Trypsin At 0.87 Resolution
 4AOQ_A Chain A, Cationic Trypsin In Complex With Mutated Spinacia Oleracea 
Trypsin Inhibitor Iii (soti-iii) (f14a)
 4AOQ_B Chain B, Cationic Trypsin In Complex With Mutated Spinacia Oleracea 
Trypsin Inhibitor Iii (soti-iii) (f14a)
 4AOQ_C Chain C, Cationic Trypsin In Complex With Mutated Spinacia Oleracea 
Trypsin Inhibitor Iii (soti-iii) (f14a)
 4AOR_A Chain A, Cationic Trypsin In Complex With The Spinacia Oleracea 
Trypsin Inhibitor Iii (soti-iii)
 4AOR_B Chain B, Cationic Trypsin In Complex With The Spinacia Oleracea 
Trypsin Inhibitor Iii (soti-iii)
 4AOR_C Chain C, Cationic Trypsin In Complex With The Spinacia Oleracea 
Trypsin Inhibitor Iii (soti-iii)
 4J2Y_B Chain B, Crystal Structure Of A Plant Trypsin Inhibitor Ecti 
In Complex With Bovine Trypsin.
 4HGC_A Chain A, Crystal Structure Of Bovine Trypsin Complexed With Sfti-1 
Analog Containing A Peptoid Residue At Position P1
 4KTS_A Chain A, Bovine Trypsin In Complex With Microviridin J At Ph 
8.5
 4KTU_A Chain A, Bovine Trypsin In Complex With Microviridin J At Ph 
6.5
 4NCY_A Chain A, In Situ Trypsin Crystallized On A Mitegen Micromesh 
With Imidazole Ligand
 4TPY_A Chain A, High Throughput Screening Using Acoustic Droplet Ejection 
To Combine Protein Crystals And Chemical Libraries On 
Crystallization Plates At High Density
 4U2W_A Chain A, Atomic Resolution Crystal Structure Of Hv-bbi Protease 
Inhibitor From Amphibian Skin In Complex With Bovine Trypsin
 4YTA_A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In 
Trypsin At 1.2a Resolution
 4Y0Z_E Chain E, Trypsin In Complex With With Bpti Mutant Aminobutyric 
Acid
 4Y10_E Chain E, Trypsin In Complex With With Bpti Mutant (2s)-2-amino-4,4- 
Difluorobutanoic Acid
 4Y11_E Chain E, Trypsin In Complex With With Bpti Mutant (2s)-2-amino-4,4,4- 
Trifluorobutanoic Acid
 5F6M_A Chain A, Isotropic Trypsin Model For Comparison Of Diffuse Scattering
 4Y0Y_E Chain E, Trypsin In Complex With With Bpti
 5EG4_A Chain A, Bovine Trypsin In Complex With Cyclic Inhibitor
 5GIB_A Chain A, Succinic Acid Bound Trypsin Crystallized As Dimer
 5GIB_B Chain B, Succinic Acid Bound Trypsin Crystallized As Dimer
 5LGO_A Chain A, Trypsin Inhibitors For The Treatment Of Pancreatitis 
- Cpd 15
 5LH8_A Chain A, Trypsin Inhibitors For The Treatment Of Pancreatitis 
- Cpd 8
 5GXP_A Chain A, Cationic Trypsin With Gol/pge As Dimer At Ph 4.6
 5GXP_B Chain B, Cationic Trypsin With Gol/pge As Dimer At Ph 4.6
Length=223

 Score = 135 bits (341),  Expect = 3e-39, Method: Compositional matrix adjust.
 Identities = 80/227 (35%), Positives = 115/227 (51%), Gaps = 30/227 (13%)

Query  4    LCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEIIV  63
             CG SLI+ +W+++AAHC            + I VRLG+ N    E G E+ ++  + IV
Sbjct  24   FCGGSLINSQWVVSAAHCYK----------SGIQVRLGEDNINVVE-GNEQFISASKSIV  72

Query  64   HPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNLYE  123
            HP YN    LN DI L+ ++   +    +  + LPT     +   AG +  ++GWGN   
Sbjct  73   HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPT-----SCASAGTQCLISGWGNT--  124

Query  124  TWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDSGG  183
               SS  S P VL+ +  PI+    C+ +   +IT NMFCAG+    +   D+C+GDSGG
Sbjct  125  --KSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGK---DSCQGDSGG  179

Query  184  PFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVI  230
            P V            GIVSWG GC +  K G YT +     W+K+ I
Sbjct  180  PVVCSGKLQ------GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI  220


>1G3B_A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base 
Magnesium(Ii) Chelate
 1G3C_A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff Base 
Iron(Iii) Chelate
 1G3D_A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base 
Copper (Ii) Chelate
 1G3E_A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff-Base 
Copper (Ii) Chelate
Length=228

 Score = 135 bits (341),  Expect = 4e-39, Method: Compositional matrix adjust.
 Identities = 80/227 (35%), Positives = 115/227 (51%), Gaps = 30/227 (13%)

Query  4    LCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEIIV  63
             CG SLI+ +W+++AAHC            + I VRLG+ N    E G E+ ++  + IV
Sbjct  29   FCGGSLINSQWVVSAAHCYK----------SGIQVRLGEDNINVVE-GNEQFISASKSIV  77

Query  64   HPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNLYE  123
            HP YN    LN DI L+ ++   +    +  + LPT     +   AG +  ++GWGN   
Sbjct  78   HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPT-----SCASAGTQCLISGWGNT--  129

Query  124  TWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDSGG  183
               SS  S P VL+ +  PI+    C+ +   +IT NMFCAG+    +   D+C+GDSGG
Sbjct  130  --KSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGK---DSCQGDSGG  184

Query  184  PFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVI  230
            P V            GIVSWG GC +  K G YT +     W+K+ I
Sbjct  185  PVVCSGKLQ------GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI  225


>2FI4_E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In 
Complex With Trypsin
 2FTL_E Chain E, Crystal Structure Of Trypsin Complexed With Bpti At 
100k
Length=223

 Score = 135 bits (340),  Expect = 4e-39, Method: Compositional matrix adjust.
 Identities = 80/227 (35%), Positives = 115/227 (51%), Gaps = 30/227 (13%)

Query  4    LCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEIIV  63
             CG SLI+ +W+++AAHC            + I VRLG+ N    E G E+ ++  + IV
Sbjct  24   FCGGSLINSQWVVSAAHCYK----------SGIQVRLGEDNINVVE-GNEQFISASKSIV  72

Query  64   HPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNLYE  123
            HP YN    LN DI L+ ++   +    +  + LPT     +   AG +  ++GWGN   
Sbjct  73   HPSYN-SNTLNNDIMLIKLKSAASLXSRVASISLPT-----SCASAGTQCLISGWGNT--  124

Query  124  TWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDSGG  183
               SS  S P VL+ +  PI+    C+ +   +IT NMFCAG+    +   D+C+GDSGG
Sbjct  125  --KSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGK---DSCQGDSGG  179

Query  184  PFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVI  230
            P V            GIVSWG GC +  K G YT +     W+K+ I
Sbjct  180  PVVCSGKLQ------GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI  220


>1TGS_Z Chain Z, Three-Dimensional Structure Of The Complex Between Pancreatic 
Secretory Inhibitor (Kazal Type) And Trypsinogen At 
1.8 Angstroms Resolution. Structure Solution, Crystallographic 
Refinement And Preliminary Structural Interpretation
 2TGP_Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide 
Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors
 2TPI_Z Chain Z, On The Disordered Activation Domain In Trypsinogen. 
Chemical Labelling And Low-Temperature Crystallography
 3TPI_Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide 
Groups In Trypsin, Trypsinogen And Its Complexes With Inhibitors
 4TPI_Z Chain Z, The Refined 2.2-angstroms (0.22-nm) X-ray Crystal Structure 
Of The Ternary Complex Formed By Bovine Trypsinogen, 
Valine-valine And The Arg15 Analogue Of Bovine Pancreatic Trypsin 
Inhibitor
 1BTZ_A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine 
Proteases Selected By Binding Or Chemistry On An Enzyme Surface
 1BTX_A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine 
Proteases Selected By Binding Or Chemistry On An Enzyme Surface
 1BTW_A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine 
Proteases Selected By Binding Or Chemistry On An Enzyme Surface
 1BTP_A Chain A, Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4- 
(Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-N- 
Allylglycine Methanesulfonate To Bovine Trypsin, Revealed 
By The Crystal Structure Of The Complex
 1BTY_A Chain A, Crystal Structure Of Beta-Trypsin In Complex With Benzamidine
 1TGB_A Chain A, Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms 
Resolution. Ii. Crystallographic Refinement, Refined Crystal 
Structure And Comparison With Bovine Trypsin
 1TGC_A Chain A, On The Disordered Activation Domain In Trypsinogen. 
Chemical Labelling And Low-Temperature Crystallography
 1TGN_A Chain A, Structure Of Bovine Trypsinogen At 1.9 Angstroms Resolution
 1TGT_A Chain A, On The Disordered Activation Domain In Trypsinogen. 
Chemical Labelling And Low-Temperature Crystallography
 1TNG_A Chain A, Prediction Of Novel Serine Protease Inhibitors
 1TNH_A Chain A, Prediction Of Novel Serine Protease Inhibitors
 1TNI_A Chain A, Prediction Of Novel Serine Protease Inhibitors
 1TNJ_A Chain A, Prediction Of Novel Serine Protease Inhibitors
 1TNK_A Chain A, Prediction Of Novel Serine Protease Inhibitors
 1TNL_A Chain A, Prediction Of Novel Serine Protease Inhibitors
 2TGA_A Chain A, On The Disordered Activation Domain In Trypsinogen. 
Chemical Labelling And Low-Temperature Crystallography
 2TGD_A Chain A, Lack Of The Transition State Stabilization Site Is A 
Factor In The Inactivity Of Trypsinogen, A Serine Protease 
Zymogen. Structure Of Dfp Inhibited Bovine Trypsinogen At 2.1 
Angstroms Resolution
 2TGT_A Chain A, On The Disordered Activation Domain In Trypsinogen. 
Chemical Labelling And Low-Temperature Crystallography
Length=229

 Score = 135 bits (340),  Expect = 4e-39, Method: Compositional matrix adjust.
 Identities = 80/227 (35%), Positives = 115/227 (51%), Gaps = 30/227 (13%)

Query  4    LCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEIIV  63
             CG SLI+ +W+++AAHC            + I VRLG+ N    E G E+ ++  + IV
Sbjct  30   FCGGSLINSQWVVSAAHCYK----------SGIQVRLGEDNINVVE-GNEQFISASKSIV  78

Query  64   HPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNLYE  123
            HP YN    LN DI L+ ++   +    +  + LPT     +   AG +  ++GWGN   
Sbjct  79   HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPT-----SCASAGTQCLISGWGNT--  130

Query  124  TWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDSGG  183
               SS  S P VL+ +  PI+    C+ +   +IT NMFCAG+    +   D+C+GDSGG
Sbjct  131  --KSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGK---DSCQGDSGG  185

Query  184  PFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVI  230
            P V            GIVSWG GC +  K G YT +     W+K+ I
Sbjct  186  PVVCSGKLQ------GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI  226


>1ZZZ_A Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
Length=237

 Score = 135 bits (340),  Expect = 6e-39, Method: Compositional matrix adjust.
 Identities = 80/227 (35%), Positives = 115/227 (51%), Gaps = 30/227 (13%)

Query  4    LCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEIIV  63
             CG SLI+ +W+++AAHC            + I VRLG+ N    E G E+ ++  + IV
Sbjct  38   FCGGSLINSQWVVSAAHCYK----------SGIQVRLGEDNINVVE-GNEQFISASKSIV  86

Query  64   HPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNLYE  123
            HP YN    LN DI L+ ++   +    +  + LPT     +   AG +  ++GWGN   
Sbjct  87   HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPT-----SCASAGTQCLISGWGNT--  138

Query  124  TWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDSGG  183
               SS  S P VL+ +  PI+    C+ +   +IT NMFCAG+    +   D+C+GDSGG
Sbjct  139  --KSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGK---DSCQGDSGG  193

Query  184  PFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVI  230
            P V            GIVSWG GC +  K G YT +     W+K+ I
Sbjct  194  PVVCSGKLQ------GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI  234


>1MCT_A Chain A, The Refined 1.6 Angstroms Resolution Crystal Structure 
Of The Complex Formed Between Porcine Beta-trypsin And Mcti-a, 
A Trypsin Inhibitor Of Squash Family
 1QQU_A Chain A, Crystal Structure Of Porcine Beta Trypsin With Bound 
Acetate Ion
 1FMG_A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.04% 
Polydocanol
 1FN6_A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.1% 
Polydocanol
 1FNI_A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01% 
Polydocanol
Length=223

 Score = 135 bits (339),  Expect = 6e-39, Method: Compositional matrix adjust.
 Identities = 82/227 (36%), Positives = 116/227 (51%), Gaps = 30/227 (13%)

Query  4    LCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEIIV  63
             CG SLI+ +W+++AAHC            + I VRLG+HN    E G E+ +   +II 
Sbjct  24   FCGGSLINSQWVVSAAHCYK----------SRIQVRLGEHNIDVLE-GNEQFINAAKIIT  72

Query  64   HPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNLYE  123
            HP +N    L+ DI L+ +  P T    +  V LP     ++   AG +  ++GWGN   
Sbjct  73   HPNFN-GNTLDNDIMLIKLSSPATLNSRVATVSLP-----RSCAAAGTECLISGWGNT--  124

Query  124  TWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDSGG  183
               SS  S P++LQ +  P++    C+ S   +IT NM C GF    Q   D+C+GDSGG
Sbjct  125  --KSSGSSYPSLLQCLKAPVLSNSSCKSSYPGQITGNMICVGFL---QGGKDSCQGDSGG  179

Query  184  PFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVI  230
            P V      N   Q GIVSWG GC +  K G YT +     W+++ I
Sbjct  180  PVVC-----NGQLQ-GIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTI  220


>2TLD_E Chain E, Crystal Structure Of An Engineered Subtilisin Inhibitor 
Complexed With Bovine Trypsin
Length=220

 Score = 134 bits (338),  Expect = 7e-39, Method: Compositional matrix adjust.
 Identities = 81/227 (36%), Positives = 116/227 (51%), Gaps = 33/227 (15%)

Query  4    LCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDEIIV  63
             CG SLI+ +W+++AAHC            + I VRLG+ N    E G E+ ++  + IV
Sbjct  24   FCGGSLINSQWVVSAAHCYK----------SGIQVRLGEDNINVVE-GNEQFISASKSIV  72

Query  64   HPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGNLYE  123
            HP YN    LN DI L+ ++   +    +  + LPT     +   AG +  ++GWGN   
Sbjct  73   HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPT-----SCASAGTQCLISGWGNT--  124

Query  124  TWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGDSGG  183
               SS  S P VL+ +  PI+    C+ +   +IT NMFCAG      + GD+C+GDSGG
Sbjct  125  --KSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGL-----EGGDSCQGDSGG  177

Query  184  PFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVI  230
            P V            GIVSWG GC ++ K G YT +     W+K+ I
Sbjct  178  PVVCSGKLQ------GIVSWGSGCAKN-KPGVYTKVCNYVSWIKQTI  217


>1FXY_A Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibited With 
D-Phe-Pro-Arg- Chloromethylketone
Length=228

 Score = 135 bits (339),  Expect = 8e-39, Method: Compositional matrix adjust.
 Identities = 83/230 (36%), Positives = 121/230 (53%), Gaps = 28/230 (12%)

Query  1    QELLCGASLISDEWILTAAHCILYPPWNKNFTINDILVRLGKHNRAKFEKGTEKIVAIDE  60
             E  CG +++S+ +ILTAAHC+        +      VR+G  N  + E+G E +  ++ 
Sbjct  23   NEGFCGGTILSEFYILTAAHCL--------YQAKRFKVRVGDRNTEQ-EEGGEAVHEVEV  73

Query  61   IIVHPKYNWKENLNRDIALLHMRRPITFTDEIHPVCLPTKQVAKTLMFAGYKGRVTGWGN  120
            +I H ++  KE  + DIA+L ++ PITF   + P  LPT   A      G K  ++GWGN
Sbjct  74   VIKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPASLPTAPPA-----TGTKCLISGWGN  127

Query  121  LYETWSSSPKSLPTVLQQIHLPIVEQDICRDSTSIRITDNMFCAGFKPEEQKTGDACEGD  180
                 +SS    P  LQ +  P++ Q  C  S   +IT NMFC GF    +   D+C+GD
Sbjct  128  T----ASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFL---EGGKDSCQGD  180

Query  181  SGGPFVMKSPDDNRWYQIGIVSWGEGCDRDGKYGFYTHLFRMRRWMKKVI  230
            SGGP V      N   Q G+VSWG+GC +  K G YT ++   +W+K  I
Sbjct  181  SGGPVVC-----NGQLQ-GVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTI  224


  Database: PDB protein database
    Posted date:  Dec 3, 2016  10:53 AM
  Number of letters in database: 21,903,153
  Number of sequences in database:  88,033

Lambda      K        H
   0.321    0.139    0.456 
Gapped
Lambda      K        H
   0.267   0.0410    0.140 
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 88033
Number of Hits to DB: 67635
Number of extensions: 136
Number of successful extensions: 116
Number of sequences better than 100: 43
Number of HSP's better than 100 without gapping: 0
Number of HSP's gapped: 48
Number of HSP's successfully gapped: 43
Length of query: 239
Length of database: 21903153
Length adjustment: 99
Effective length of query: 140
Effective length of database: 13187886
Effective search space: 1846304040
Effective search space used: 1846304040
T: 21
A: 40
X1: 16 (7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 40 (20.0 bits)
S2: 51 (24.3 bits)
ka-blk-alpha gapped: 1.9
ka-blk-alpha ungapped: 0.7916
ka-blk-alpha_v gapped: 42.6028
ka-blk-alpha_v ungapped: 4.96466
ka-blk-sigma gapped: 43.6362




